| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sequence Analysis, DNA | 152 | 2025 | 1723 | 8.420 |
Why?
|
| Genome, Human | 73 | 2026 | 1322 | 6.170 |
Why?
|
| Exome | 101 | 2025 | 1075 | 5.850 |
Why?
|
| Genomics | 92 | 2026 | 1619 | 5.520 |
Why?
|
| Genome | 53 | 2022 | 465 | 4.910 |
Why?
|
| Mutation | 165 | 2026 | 6131 | 4.810 |
Why?
|
| Genetic Variation | 80 | 2026 | 1556 | 4.590 |
Why?
|
| Polymorphism, Single Nucleotide | 96 | 2026 | 2847 | 3.670 |
Why?
|
| Intellectual Disability | 32 | 2026 | 1080 | 3.580 |
Why?
|
| Genetic Predisposition to Disease | 79 | 2026 | 3425 | 3.170 |
Why?
|
| Evolution, Molecular | 44 | 2020 | 656 | 3.000 |
Why?
|
| High-Throughput Nucleotide Sequencing | 60 | 2025 | 915 | 2.880 |
Why?
|
| Genetic Diseases, Inborn | 25 | 2026 | 470 | 2.860 |
Why?
|
| Neurodevelopmental Disorders | 17 | 2026 | 622 | 2.660 |
Why?
|
| Phenotype | 91 | 2026 | 4475 | 2.600 |
Why?
|
| Pedigree | 89 | 2026 | 1683 | 2.550 |
Why?
|
| Alleles | 54 | 2026 | 1685 | 2.470 |
Why?
|
| Genetic Testing | 29 | 2026 | 1100 | 2.420 |
Why?
|
| Humans | 556 | 2026 | 130380 | 2.410 |
Why?
|
| DNA Copy Number Variations | 35 | 2026 | 1031 | 2.340 |
Why?
|
| Whole Genome Sequencing | 24 | 2026 | 359 | 2.320 |
Why?
|
| Software | 32 | 2026 | 737 | 2.270 |
Why?
|
| Exons | 43 | 2023 | 764 | 2.240 |
Why?
|
| Abnormalities, Multiple | 19 | 2022 | 967 | 2.230 |
Why?
|
| Base Sequence | 97 | 2022 | 2767 | 2.170 |
Why?
|
| Genetic Association Studies | 44 | 2025 | 823 | 2.040 |
Why?
|
| Human Genome Project | 11 | 2020 | 55 | 1.870 |
Why?
|
| Databases, Genetic | 29 | 2024 | 507 | 1.860 |
Why?
|
| Mutation, Missense | 29 | 2021 | 931 | 1.700 |
Why?
|
| Pharmacogenetics | 7 | 2024 | 203 | 1.670 |
Why?
|
| Molecular Sequence Data | 100 | 2016 | 3507 | 1.670 |
Why?
|
| Developmental Disabilities | 11 | 2026 | 773 | 1.590 |
Why?
|
| Male | 258 | 2026 | 64524 | 1.550 |
Why?
|
| Female | 270 | 2026 | 70281 | 1.520 |
Why?
|
| DNA-Binding Proteins | 24 | 2026 | 1976 | 1.480 |
Why?
|
| Membrane Proteins | 30 | 2023 | 1605 | 1.450 |
Why?
|
| Genome-Wide Association Study | 39 | 2026 | 1838 | 1.450 |
Why?
|
| Genomic Structural Variation | 9 | 2025 | 95 | 1.440 |
Why?
|
| Genome, Insect | 15 | 2020 | 81 | 1.420 |
Why?
|
| Precision Medicine | 10 | 2025 | 381 | 1.390 |
Why?
|
| Genetics, Medical | 10 | 2022 | 120 | 1.310 |
Why?
|
| Genotype | 48 | 2025 | 2605 | 1.300 |
Why?
|
| DNA, Complementary | 17 | 2021 | 431 | 1.250 |
Why?
|
| Mosaicism | 6 | 2026 | 250 | 1.230 |
Why?
|
| Craniofacial Abnormalities | 11 | 2022 | 253 | 1.180 |
Why?
|
| Endovascular Procedures | 8 | 2022 | 781 | 1.170 |
Why?
|
| Gene Library | 22 | 2025 | 211 | 1.170 |
Why?
|
| Animals | 171 | 2026 | 33924 | 1.170 |
Why?
|
| Polymerase Chain Reaction | 38 | 2024 | 1458 | 1.150 |
Why?
|
| Gene Frequency | 30 | 2024 | 739 | 1.150 |
Why?
|
| Muscle Hypotonia | 9 | 2022 | 195 | 1.100 |
Why?
|
| Chromosome Mapping | 27 | 2021 | 1053 | 1.090 |
Why?
|
| Microcephaly | 13 | 2023 | 348 | 1.070 |
Why?
|
| Urogenital Abnormalities | 9 | 2023 | 159 | 1.050 |
Why?
|
| Computational Biology | 30 | 2021 | 869 | 1.050 |
Why?
|
| Phylogeny | 33 | 2025 | 706 | 1.040 |
Why?
|
| Homozygote | 24 | 2024 | 540 | 1.040 |
Why?
|
| Sequence Alignment | 20 | 2025 | 585 | 1.010 |
Why?
|
| Haplotypes | 16 | 2026 | 522 | 1.010 |
Why?
|
| Open Reading Frames | 14 | 2021 | 198 | 0.990 |
Why?
|
| Limb Deformities, Congenital | 8 | 2022 | 118 | 0.990 |
Why?
|
| Charcot-Marie-Tooth Disease | 9 | 2023 | 237 | 0.990 |
Why?
|
| Genetics, Population | 18 | 2024 | 180 | 0.970 |
Why?
|
| Nuclear Proteins | 18 | 2021 | 1229 | 0.950 |
Why?
|
| Transcriptome | 16 | 2020 | 1130 | 0.950 |
Why?
|
| Pancreatic Neoplasms | 10 | 2021 | 742 | 0.950 |
Why?
|
| Musculoskeletal Abnormalities | 3 | 2022 | 68 | 0.940 |
Why?
|
| DNA Mutational Analysis | 32 | 2021 | 789 | 0.910 |
Why?
|
| Nerve Tissue Proteins | 15 | 2026 | 1091 | 0.900 |
Why?
|
| Heterozygote | 27 | 2021 | 721 | 0.900 |
Why?
|
| Child | 96 | 2026 | 26161 | 0.900 |
Why?
|
| Dwarfism | 7 | 2022 | 105 | 0.880 |
Why?
|
| INDEL Mutation | 12 | 2022 | 94 | 0.880 |
Why?
|
| Blood Vessel Prosthesis Implantation | 7 | 2022 | 744 | 0.880 |
Why?
|
| Cardiovascular Diseases | 9 | 2026 | 2110 | 0.870 |
Why?
|
| Child, Preschool | 77 | 2026 | 14984 | 0.840 |
Why?
|
| DNA | 32 | 2023 | 1419 | 0.840 |
Why?
|
| Genetic Speciation | 6 | 2020 | 25 | 0.820 |
Why?
|
| Adult | 91 | 2026 | 31121 | 0.810 |
Why?
|
| Schizophrenia | 6 | 2025 | 326 | 0.800 |
Why?
|
| Information Dissemination | 7 | 2020 | 195 | 0.800 |
Why?
|
| Biomarkers, Tumor | 8 | 2025 | 1606 | 0.790 |
Why?
|
| Chromosomes, Human, Pair 12 | 7 | 2015 | 92 | 0.770 |
Why?
|
| Aorta, Thoracic | 4 | 2023 | 527 | 0.760 |
Why?
|
| Medical Informatics | 2 | 2021 | 106 | 0.740 |
Why?
|
| Spinal Cord Ischemia | 1 | 2022 | 30 | 0.720 |
Why?
|
| Carbon Dioxide | 1 | 2023 | 272 | 0.710 |
Why?
|
| Primates | 4 | 2020 | 81 | 0.710 |
Why?
|
| Transcription Factors | 23 | 2023 | 2457 | 0.710 |
Why?
|
| Carrier Proteins | 13 | 2023 | 1006 | 0.710 |
Why?
|
| Molecular Sequence Annotation | 14 | 2021 | 150 | 0.700 |
Why?
|
| Middle Aged | 63 | 2026 | 28376 | 0.700 |
Why?
|
| Macaca mulatta | 7 | 2018 | 495 | 0.700 |
Why?
|
| Syndrome | 16 | 2023 | 1160 | 0.690 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 10 | 2022 | 583 | 0.690 |
Why?
|
| Germ-Line Mutation | 11 | 2022 | 373 | 0.690 |
Why?
|
| Models, Genetic | 20 | 2020 | 748 | 0.690 |
Why?
|
| Aortic Aneurysm, Thoracic | 4 | 2022 | 690 | 0.680 |
Why?
|
| Transplants | 1 | 2021 | 38 | 0.680 |
Why?
|
| Awards and Prizes | 1 | 2022 | 62 | 0.680 |
Why?
|
| Immunologic Deficiency Syndromes | 6 | 2024 | 207 | 0.670 |
Why?
|
| Proteins | 14 | 2018 | 1015 | 0.660 |
Why?
|
| X Chromosome | 12 | 2020 | 329 | 0.660 |
Why?
|
| Alkyl and Aryl Transferases | 3 | 2016 | 17 | 0.660 |
Why?
|
| Contig Mapping | 9 | 2006 | 51 | 0.650 |
Why?
|
| Adolescent | 63 | 2026 | 20749 | 0.640 |
Why?
|
| Laboratories | 2 | 2024 | 79 | 0.640 |
Why?
|
| Cloning, Molecular | 18 | 2009 | 782 | 0.630 |
Why?
|
| Bees | 6 | 2015 | 52 | 0.630 |
Why?
|
| Frameshift Mutation | 11 | 2023 | 204 | 0.620 |
Why?
|
| Algorithms | 15 | 2025 | 1679 | 0.620 |
Why?
|
| Infant | 52 | 2026 | 13269 | 0.620 |
Why?
|
| Codon, Nonsense | 10 | 2021 | 140 | 0.620 |
Why?
|
| Amino Acid Sequence | 33 | 2020 | 2409 | 0.610 |
Why?
|
| Computer Security | 1 | 2019 | 30 | 0.600 |
Why?
|
| RNA, Messenger | 24 | 2023 | 2567 | 0.600 |
Why?
|
| Cardiology | 2 | 2022 | 510 | 0.600 |
Why?
|
| Chromosome Aberrations | 7 | 2024 | 575 | 0.590 |
Why?
|
| HIV-1 | 9 | 2002 | 480 | 0.590 |
Why?
|
| Multigene Family | 12 | 2020 | 291 | 0.590 |
Why?
|
| Osteogenesis Imperfecta | 6 | 2023 | 172 | 0.590 |
Why?
|
| Genetic Heterogeneity | 9 | 2024 | 133 | 0.590 |
Why?
|
| DNA, Neoplasm | 4 | 2016 | 286 | 0.590 |
Why?
|
| Osteochondrodysplasias | 5 | 2019 | 68 | 0.580 |
Why?
|
| Organ Transplantation | 1 | 2021 | 168 | 0.580 |
Why?
|
| Genome, Bacterial | 10 | 2017 | 208 | 0.580 |
Why?
|
| Genetic Privacy | 2 | 2012 | 43 | 0.580 |
Why?
|
| Medical Records | 1 | 2019 | 177 | 0.580 |
Why?
|
| Young Adult | 39 | 2026 | 9992 | 0.580 |
Why?
|
| Cohort Studies | 29 | 2026 | 5069 | 0.570 |
Why?
|
| Genome, Viral | 6 | 2025 | 159 | 0.570 |
Why?
|
| Fasting | 5 | 2016 | 303 | 0.570 |
Why?
|
| Embolic Protection Devices | 1 | 2018 | 8 | 0.560 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2021 | 214 | 0.560 |
Why?
|
| Intracranial Embolism | 1 | 2018 | 25 | 0.550 |
Why?
|
| Embolism, Air | 1 | 2018 | 21 | 0.550 |
Why?
|
| Electronic Health Records | 4 | 2023 | 812 | 0.550 |
Why?
|
| Population Health | 3 | 2024 | 35 | 0.550 |
Why?
|
| Rare Diseases | 5 | 2025 | 207 | 0.550 |
Why?
|
| Linkage Disequilibrium | 10 | 2014 | 317 | 0.540 |
Why?
|
| 46, XX Disorders of Sex Development | 3 | 2023 | 26 | 0.540 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 10 | 1993 | 34 | 0.540 |
Why?
|
| Brain Neoplasms | 9 | 2023 | 1350 | 0.540 |
Why?
|
| Killer Cells, Natural | 6 | 2024 | 342 | 0.530 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 19 | 2008 | 333 | 0.530 |
Why?
|
| Iduronate Sulfatase | 4 | 1998 | 20 | 0.530 |
Why?
|
| Gene Expression Profiling | 16 | 2021 | 1829 | 0.520 |
Why?
|
| Genetic Markers | 10 | 2019 | 597 | 0.520 |
Why?
|
| Actins | 4 | 2024 | 315 | 0.520 |
Why?
|
| Genetic Loci | 8 | 2021 | 356 | 0.520 |
Why?
|
| Anodontia | 4 | 2018 | 33 | 0.510 |
Why?
|
| Heart Defects, Congenital | 10 | 2025 | 1875 | 0.510 |
Why?
|
| Bipolar Disorder | 4 | 2025 | 311 | 0.510 |
Why?
|
| DNA Primers | 14 | 2015 | 606 | 0.510 |
Why?
|
| Congenital Disorders of Glycosylation | 3 | 2025 | 50 | 0.510 |
Why?
|
| Farnesyltranstransferase | 1 | 2016 | 8 | 0.510 |
Why?
|
| Diphosphates | 1 | 2016 | 8 | 0.510 |
Why?
|
| Insect Proteins | 7 | 2020 | 96 | 0.500 |
Why?
|
| Terpenes | 1 | 2016 | 32 | 0.500 |
Why?
|
| Autism Spectrum Disorder | 3 | 2020 | 445 | 0.500 |
Why?
|
| Tumor Suppressor Proteins | 8 | 2023 | 490 | 0.490 |
Why?
|
| Gene Expression Regulation | 14 | 2021 | 2356 | 0.490 |
Why?
|
| Patient Selection | 1 | 2020 | 720 | 0.490 |
Why?
|
| Biological Evolution | 7 | 2020 | 227 | 0.490 |
Why?
|
| Mice | 58 | 2024 | 18213 | 0.490 |
Why?
|
| Adaptor Proteins, Signal Transducing | 8 | 2017 | 622 | 0.490 |
Why?
|
| Echinodermata | 2 | 2015 | 5 | 0.480 |
Why?
|
| Aged | 41 | 2026 | 20888 | 0.480 |
Why?
|
| Genes, Recessive | 9 | 2026 | 199 | 0.480 |
Why?
|
| Genes, X-Linked | 4 | 2016 | 60 | 0.470 |
Why?
|
| Sequence Deletion | 13 | 2021 | 521 | 0.470 |
Why?
|
| Family | 12 | 2022 | 579 | 0.470 |
Why?
|
| Vesicular Transport Proteins | 4 | 2021 | 140 | 0.470 |
Why?
|
| Y Chromosome | 4 | 2020 | 47 | 0.460 |
Why?
|
| Drosophila melanogaster | 11 | 2016 | 850 | 0.460 |
Why?
|
| Gene Dosage | 10 | 2020 | 439 | 0.460 |
Why?
|
| Pathology, Molecular | 5 | 2018 | 63 | 0.460 |
Why?
|
| Genetic Research | 2 | 2006 | 56 | 0.460 |
Why?
|
| Gene Regulatory Networks | 6 | 2018 | 384 | 0.460 |
Why?
|
| Child Development Disorders, Pervasive | 5 | 2014 | 82 | 0.460 |
Why?
|
| Lipids | 4 | 2023 | 562 | 0.450 |
Why?
|
| Blepharophimosis | 4 | 2021 | 25 | 0.450 |
Why?
|
| Conserved Sequence | 13 | 2020 | 281 | 0.450 |
Why?
|
| RNA-Binding Proteins | 6 | 2022 | 541 | 0.450 |
Why?
|
| Kidney Neoplasms | 5 | 2018 | 420 | 0.450 |
Why?
|
| Aging | 9 | 2025 | 1253 | 0.440 |
Why?
|
| Neoplasm Proteins | 6 | 2023 | 683 | 0.440 |
Why?
|
| Mucopolysaccharidosis II | 4 | 1998 | 19 | 0.440 |
Why?
|
| Stroke | 1 | 2023 | 1057 | 0.440 |
Why?
|
| Neoplasms | 10 | 2026 | 2944 | 0.440 |
Why?
|
| Polymorphism, Genetic | 14 | 2019 | 776 | 0.440 |
Why?
|
| Epilepsy, Generalized | 3 | 2022 | 61 | 0.430 |
Why?
|
| Gene Rearrangement | 8 | 2026 | 326 | 0.430 |
Why?
|
| Metabolome | 6 | 2022 | 325 | 0.430 |
Why?
|
| Chromosomes, Human, X | 6 | 2021 | 155 | 0.420 |
Why?
|
| Genes | 10 | 2011 | 310 | 0.420 |
Why?
|
| Selection, Genetic | 12 | 2020 | 156 | 0.420 |
Why?
|
| Siblings | 6 | 2024 | 202 | 0.420 |
Why?
|
| Point Mutation | 5 | 2016 | 334 | 0.420 |
Why?
|
| Cell Cycle Proteins | 11 | 2020 | 714 | 0.420 |
Why?
|
| Carcinoma, Renal Cell | 4 | 2018 | 222 | 0.420 |
Why?
|
| Stents | 6 | 2023 | 780 | 0.420 |
Why?
|
| Boron Compounds | 4 | 1999 | 31 | 0.410 |
Why?
|
| Quality of Life | 2 | 2023 | 2071 | 0.410 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 568 | 0.410 |
Why?
|
| Gene Amplification | 10 | 2020 | 222 | 0.410 |
Why?
|
| Cholesterol, LDL | 6 | 2026 | 614 | 0.410 |
Why?
|
| Genes, Dominant | 8 | 2020 | 245 | 0.410 |
Why?
|
| Atherosclerosis | 5 | 2023 | 949 | 0.400 |
Why?
|
| Coronary Disease | 4 | 2023 | 628 | 0.400 |
Why?
|
| Genotyping Techniques | 5 | 2025 | 110 | 0.400 |
Why?
|
| Real-Time Polymerase Chain Reaction | 4 | 2025 | 528 | 0.400 |
Why?
|
| Alu Elements | 2 | 2026 | 66 | 0.400 |
Why?
|
| Genes, Insect | 7 | 2015 | 109 | 0.400 |
Why?
|
| Arthropods | 3 | 2020 | 22 | 0.400 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2026 | 1443 | 0.400 |
Why?
|
| Transcription, Genetic | 11 | 2018 | 1391 | 0.390 |
Why?
|
| Databases, Nucleic Acid | 4 | 2017 | 72 | 0.390 |
Why?
|
| Coronary Artery Disease | 4 | 2026 | 890 | 0.390 |
Why?
|
| Connexins | 1 | 2013 | 64 | 0.390 |
Why?
|
| Pilot Projects | 7 | 2023 | 1452 | 0.390 |
Why?
|
| Micrognathism | 5 | 2017 | 64 | 0.390 |
Why?
|
| Mutation Rate | 5 | 2018 | 68 | 0.390 |
Why?
|
| Hyperlipoproteinemia Type II | 2 | 2026 | 121 | 0.390 |
Why?
|
| Nervous System Diseases | 4 | 2019 | 396 | 0.390 |
Why?
|
| HapMap Project | 2 | 2012 | 13 | 0.390 |
Why?
|
| Consensus Sequence | 2 | 2011 | 55 | 0.390 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2015 | 1004 | 0.380 |
Why?
|
| Pharmacogenomic Testing | 2 | 2024 | 47 | 0.380 |
Why?
|
| Microfilament Proteins | 6 | 2018 | 272 | 0.380 |
Why?
|
| Sequence Homology, Nucleic Acid | 12 | 2008 | 256 | 0.380 |
Why?
|
| Language Development Disorders | 1 | 2014 | 177 | 0.380 |
Why?
|
| Consanguinity | 10 | 2020 | 119 | 0.380 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2014 | 94 | 0.380 |
Why?
|
| DNA Transposable Elements | 9 | 2020 | 182 | 0.380 |
Why?
|
| Arthrogryposis | 3 | 2019 | 37 | 0.380 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2006 | 91 | 0.380 |
Why?
|
| Bone Diseases, Developmental | 5 | 2017 | 60 | 0.380 |
Why?
|
| Epilepsy | 5 | 2021 | 872 | 0.380 |
Why?
|
| DEAD-box RNA Helicases | 4 | 2023 | 159 | 0.370 |
Why?
|
| DNA, Viral | 9 | 2002 | 452 | 0.370 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 3 | 2022 | 36 | 0.370 |
Why?
|
| Gene Expression Regulation, Neoplastic | 14 | 2020 | 2026 | 0.370 |
Why?
|
| Proteogenomics | 2 | 2025 | 111 | 0.370 |
Why?
|
| Heart Diseases | 5 | 2014 | 501 | 0.370 |
Why?
|
| Heterotaxy Syndrome | 3 | 2024 | 63 | 0.370 |
Why?
|
| Glioma | 4 | 2023 | 523 | 0.370 |
Why?
|
| Malformations of Cortical Development | 4 | 2018 | 60 | 0.370 |
Why?
|
| DNA-Directed DNA Polymerase | 9 | 1999 | 86 | 0.370 |
Why?
|
| Breast Neoplasms | 6 | 2025 | 2603 | 0.370 |
Why?
|
| Gorilla gorilla | 1 | 2012 | 12 | 0.370 |
Why?
|
| Repressor Proteins | 7 | 2018 | 774 | 0.370 |
Why?
|
| Chromosomes, Artificial, Bacterial | 6 | 2009 | 89 | 0.370 |
Why?
|
| Chromosome Inversion | 5 | 2006 | 72 | 0.360 |
Why?
|
| RNA, Untranslated | 6 | 2026 | 110 | 0.360 |
Why?
|
| Risk Factors | 23 | 2023 | 10937 | 0.360 |
Why?
|
| RNA Splice Sites | 6 | 2023 | 92 | 0.360 |
Why?
|
| Peripheral Nervous System Diseases | 4 | 2018 | 132 | 0.360 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2013 | 152 | 0.350 |
Why?
|
| Gene Duplication | 7 | 2024 | 360 | 0.350 |
Why?
|
| White Matter | 2 | 2026 | 219 | 0.350 |
Why?
|
| Spasms, Infantile | 3 | 2019 | 165 | 0.350 |
Why?
|
| Growth Disorders | 4 | 2016 | 183 | 0.350 |
Why?
|
| Obesity | 4 | 2017 | 2380 | 0.350 |
Why?
|
| Viral Load | 2 | 2025 | 403 | 0.340 |
Why?
|
| Mammals | 5 | 2023 | 254 | 0.340 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2011 | 72 | 0.340 |
Why?
|
| Nonsense Mediated mRNA Decay | 3 | 2021 | 39 | 0.340 |
Why?
|
| Sequence Analysis, RNA | 5 | 2025 | 419 | 0.340 |
Why?
|
| Organ Specificity | 6 | 2025 | 397 | 0.340 |
Why?
|
| Brain | 10 | 2021 | 3193 | 0.340 |
Why?
|
| Insecticide Resistance | 4 | 2020 | 30 | 0.340 |
Why?
|
| Respiratory Syncytial Virus, Human | 2 | 2025 | 233 | 0.340 |
Why?
|
| Host-Parasite Interactions | 4 | 2020 | 72 | 0.340 |
Why?
|
| Introns | 11 | 2017 | 281 | 0.340 |
Why?
|
| RNA Splicing | 7 | 2023 | 237 | 0.340 |
Why?
|
| Base Pairing | 2 | 2010 | 40 | 0.330 |
Why?
|
| Metagenomics | 4 | 2017 | 115 | 0.330 |
Why?
|
| Chromosome Deletion | 12 | 2017 | 653 | 0.330 |
Why?
|
| DNA Methylation | 11 | 2022 | 1092 | 0.330 |
Why?
|
| Lesch-Nyhan Syndrome | 5 | 1991 | 11 | 0.330 |
Why?
|
| Genomic Library | 6 | 2009 | 36 | 0.330 |
Why?
|
| Tumor Suppressor Protein p53 | 8 | 2024 | 726 | 0.330 |
Why?
|
| MicroRNAs | 10 | 2016 | 896 | 0.330 |
Why?
|
| Gene Transfer, Horizontal | 5 | 2020 | 45 | 0.330 |
Why?
|
| Aged, 80 and over | 16 | 2026 | 6779 | 0.330 |
Why?
|
| Comparative Genomic Hybridization | 11 | 2024 | 569 | 0.330 |
Why?
|
| CD4 Antigens | 4 | 1996 | 51 | 0.330 |
Why?
|
| Patient Care | 1 | 2011 | 97 | 0.330 |
Why?
|
| Endoleak | 2 | 2022 | 43 | 0.320 |
Why?
|
| Cerebellar Diseases | 3 | 2020 | 78 | 0.320 |
Why?
|
| RNA-Directed DNA Polymerase | 6 | 1997 | 37 | 0.320 |
Why?
|
| Species Specificity | 9 | 2022 | 486 | 0.320 |
Why?
|
| Oxidoreductases | 4 | 2020 | 105 | 0.320 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 2 | 2023 | 49 | 0.320 |
Why?
|
| Rats | 14 | 2018 | 3400 | 0.320 |
Why?
|
| Homeodomain Proteins | 7 | 2021 | 568 | 0.320 |
Why?
|
| Neoplasms, Second Primary | 2 | 2024 | 140 | 0.320 |
Why?
|
| Epithelial Sodium Channels | 2 | 2022 | 16 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 18 | 3 | 2024 | 59 | 0.320 |
Why?
|
| Dystonic Disorders | 1 | 2011 | 97 | 0.310 |
Why?
|
| Synteny | 8 | 2017 | 69 | 0.310 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2016 | 1215 | 0.310 |
Why?
|
| Proto-Oncogene Proteins | 7 | 2018 | 599 | 0.310 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 2 | 2022 | 66 | 0.310 |
Why?
|
| Lipoprotein(a) | 2 | 2024 | 140 | 0.310 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2025 | 385 | 0.310 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2009 | 27 | 0.310 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2024 | 282 | 0.310 |
Why?
|
| Appetite | 1 | 2009 | 38 | 0.310 |
Why?
|
| Genomic Instability | 3 | 2022 | 244 | 0.310 |
Why?
|
| Congenital Abnormalities | 3 | 2023 | 322 | 0.310 |
Why?
|
| Heteroptera | 2 | 2020 | 9 | 0.310 |
Why?
|
| Zebrafish | 13 | 2021 | 419 | 0.310 |
Why?
|
| Gene Deletion | 6 | 2016 | 769 | 0.300 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 3 | 2024 | 284 | 0.300 |
Why?
|
| Chromosomes, Human, Pair 17 | 5 | 2021 | 364 | 0.300 |
Why?
|
| Rhabdomyosarcoma | 2 | 2024 | 228 | 0.300 |
Why?
|
| Lymphoproliferative Disorders | 2 | 2021 | 216 | 0.300 |
Why?
|
| Blood Vessel Prosthesis | 4 | 2021 | 470 | 0.300 |
Why?
|
| Cell Line | 12 | 2024 | 2578 | 0.300 |
Why?
|
| Glucose | 3 | 2020 | 853 | 0.300 |
Why?
|
| Adenocarcinoma | 4 | 2024 | 987 | 0.300 |
Why?
|
| Fluorescent Dyes | 4 | 2024 | 248 | 0.300 |
Why?
|
| Insecta | 4 | 2019 | 50 | 0.300 |
Why?
|
| Genes, Tumor Suppressor | 5 | 2014 | 202 | 0.290 |
Why?
|
| Smith-Magenis Syndrome | 3 | 2019 | 107 | 0.290 |
Why?
|
| Signal Transduction | 18 | 2023 | 4675 | 0.290 |
Why?
|
| Templates, Genetic | 7 | 1999 | 54 | 0.290 |
Why?
|
| Case-Control Studies | 16 | 2025 | 3388 | 0.290 |
Why?
|
| ADAM Proteins | 3 | 2014 | 82 | 0.290 |
Why?
|
| Wnt Signaling Pathway | 4 | 2020 | 207 | 0.290 |
Why?
|
| Carcinoma, Neuroendocrine | 2 | 2021 | 41 | 0.290 |
Why?
|
| Infant, Newborn | 21 | 2023 | 8492 | 0.290 |
Why?
|
| Symporters | 2 | 2021 | 78 | 0.290 |
Why?
|
| Coatomer Protein | 2 | 2021 | 28 | 0.290 |
Why?
|
| United States | 15 | 2024 | 11819 | 0.290 |
Why?
|
| RNA, Viral | 2 | 2021 | 502 | 0.280 |
Why?
|
| Translocation, Genetic | 2 | 2024 | 348 | 0.280 |
Why?
|
| Cell Adhesion Molecules | 3 | 2018 | 225 | 0.280 |
Why?
|
| Reproducibility of Results | 12 | 2018 | 2920 | 0.280 |
Why?
|
| Receptors, Cell Surface | 5 | 2018 | 420 | 0.280 |
Why?
|
| Fibroblasts | 8 | 2023 | 857 | 0.280 |
Why?
|
| Mediator Complex | 2 | 2020 | 61 | 0.270 |
Why?
|
| Genome, Protozoan | 2 | 2020 | 26 | 0.270 |
Why?
|
| Ovarian Neoplasms | 3 | 2022 | 434 | 0.270 |
Why?
|
| Biliary Atresia | 2 | 2023 | 220 | 0.270 |
Why?
|
| Alternative Splicing | 7 | 2023 | 310 | 0.270 |
Why?
|
| Fibrillar Collagens | 2 | 2020 | 14 | 0.270 |
Why?
|
| TOR Serine-Threonine Kinases | 7 | 2023 | 427 | 0.270 |
Why?
|
| Quantitative Trait Loci | 7 | 2024 | 304 | 0.270 |
Why?
|
| Chromosome Disorders | 3 | 2019 | 317 | 0.270 |
Why?
|
| Founder Effect | 2 | 2020 | 32 | 0.270 |
Why?
|
| Rhabdomyolysis | 2 | 2019 | 35 | 0.260 |
Why?
|
| Mitochondrial Proteins | 4 | 2017 | 278 | 0.260 |
Why?
|
| Coleoptera | 2 | 2018 | 11 | 0.260 |
Why?
|
| Bone Density | 3 | 2016 | 367 | 0.260 |
Why?
|
| NF-kappa B | 2 | 2020 | 442 | 0.260 |
Why?
|
| Alopecia | 3 | 2023 | 41 | 0.260 |
Why?
|
| Atrophy | 5 | 2020 | 244 | 0.260 |
Why?
|
| Biomarkers | 6 | 2024 | 3395 | 0.260 |
Why?
|
| Multifactorial Inheritance | 5 | 2021 | 172 | 0.260 |
Why?
|
| B-Lymphocytes | 3 | 2020 | 509 | 0.260 |
Why?
|
| Endoribonucleases | 3 | 2022 | 88 | 0.260 |
Why?
|
| Mullerian Ducts | 3 | 2023 | 44 | 0.260 |
Why?
|
| GTP Phosphohydrolases | 3 | 2019 | 158 | 0.260 |
Why?
|
| Cerebral Palsy | 2 | 2021 | 86 | 0.260 |
Why?
|
| Informed Consent | 3 | 2010 | 347 | 0.260 |
Why?
|
| Collagen Type II | 3 | 2017 | 23 | 0.260 |
Why?
|
| Seizures | 6 | 2019 | 877 | 0.260 |
Why?
|
| Homeostasis | 1 | 2011 | 716 | 0.260 |
Why?
|
| Deoxyribonucleotides | 2 | 1998 | 7 | 0.260 |
Why?
|
| Social Behavior | 3 | 2020 | 211 | 0.260 |
Why?
|
| Simian Immunodeficiency Virus | 3 | 2018 | 100 | 0.250 |
Why?
|
| Cell Line, Tumor | 13 | 2020 | 3720 | 0.250 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 2 | 2019 | 157 | 0.250 |
Why?
|
| DNA, Bacterial | 7 | 2017 | 488 | 0.250 |
Why?
|
| Hemiptera | 2 | 2019 | 16 | 0.250 |
Why?
|
| Membrane Transport Proteins | 3 | 2024 | 180 | 0.250 |
Why?
|
| Germ Cells | 3 | 2024 | 200 | 0.250 |
Why?
|
| Hand Deformities, Congenital | 3 | 2017 | 95 | 0.250 |
Why?
|
| Osteoporosis | 2 | 2021 | 133 | 0.250 |
Why?
|
| Immunity | 4 | 2021 | 179 | 0.250 |
Why?
|
| Centromere | 7 | 2017 | 69 | 0.250 |
Why?
|
| Optic Atrophy | 3 | 2016 | 44 | 0.250 |
Why?
|
| Acquired Immunodeficiency Syndrome | 4 | 2018 | 217 | 0.250 |
Why?
|
| Cilia | 2 | 2020 | 75 | 0.250 |
Why?
|
| Microsatellite Repeats | 6 | 2019 | 210 | 0.240 |
Why?
|
| Scoliosis | 2 | 2020 | 157 | 0.240 |
Why?
|
| Autistic Disorder | 3 | 2022 | 395 | 0.240 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2016 | 225 | 0.240 |
Why?
|
| Molecular Diagnostic Techniques | 3 | 2016 | 170 | 0.240 |
Why?
|
| Pest Control, Biological | 4 | 2018 | 13 | 0.240 |
Why?
|
| RNA, Small Nuclear | 1 | 2026 | 49 | 0.240 |
Why?
|
| Megalencephaly | 2 | 2016 | 61 | 0.240 |
Why?
|
| Facies | 7 | 2021 | 157 | 0.230 |
Why?
|
| Cercocebus atys | 2 | 2018 | 9 | 0.230 |
Why?
|
| Genetic Linkage | 7 | 2019 | 462 | 0.230 |
Why?
|
| Energy Metabolism | 2 | 2012 | 799 | 0.230 |
Why?
|
| Lipid Metabolism | 3 | 2021 | 373 | 0.230 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2005 | 53 | 0.230 |
Why?
|
| Microtubule-Associated Proteins | 4 | 2023 | 253 | 0.230 |
Why?
|
| Proprotein Convertase 9 | 2 | 2023 | 110 | 0.230 |
Why?
|
| Internet | 5 | 2016 | 418 | 0.230 |
Why?
|
| Inheritance Patterns | 5 | 2018 | 129 | 0.230 |
Why?
|
| Whale, Killer | 2 | 2016 | 4 | 0.230 |
Why?
|
| Wnt Proteins | 4 | 2021 | 193 | 0.230 |
Why?
|
| Trinucleotide Repeats | 1 | 2005 | 83 | 0.230 |
Why?
|
| Carcinoma, Squamous Cell | 5 | 2014 | 753 | 0.230 |
Why?
|
| Information Storage and Retrieval | 2 | 2024 | 64 | 0.230 |
Why?
|
| Ischemia | 2 | 2022 | 354 | 0.230 |
Why?
|
| Atrial Fibrillation | 3 | 2020 | 733 | 0.220 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2018 | 836 | 0.220 |
Why?
|
| Molecular Probe Techniques | 1 | 2005 | 23 | 0.220 |
Why?
|
| Heart Conduction System | 2 | 2018 | 161 | 0.220 |
Why?
|
| DNA Replication | 6 | 2019 | 358 | 0.220 |
Why?
|
| Datasets as Topic | 4 | 2020 | 100 | 0.220 |
Why?
|
| Cytochrome P-450 CYP2D6 | 2 | 2022 | 33 | 0.220 |
Why?
|
| Dishevelled Proteins | 3 | 2020 | 42 | 0.220 |
Why?
|
| Glucosyltransferases | 1 | 2025 | 44 | 0.220 |
Why?
|
| Phosphoproteins | 3 | 2017 | 454 | 0.220 |
Why?
|
| Alzheimer Disease | 2 | 2026 | 876 | 0.220 |
Why?
|
| Retrospective Studies | 19 | 2024 | 17606 | 0.220 |
Why?
|
| Retinitis Pigmentosa | 3 | 2015 | 88 | 0.220 |
Why?
|
| Oligodeoxyribonucleotides | 4 | 2007 | 123 | 0.220 |
Why?
|
| Gene Expression | 11 | 2017 | 1494 | 0.220 |
Why?
|
| Mitochondria | 2 | 2023 | 764 | 0.220 |
Why?
|
| Treatment Outcome | 10 | 2022 | 12856 | 0.220 |
Why?
|
| Supervised Machine Learning | 1 | 2024 | 10 | 0.220 |
Why?
|
| Diabetes Mellitus | 3 | 2023 | 890 | 0.220 |
Why?
|
| Databases, Factual | 6 | 2021 | 1221 | 0.220 |
Why?
|
| Prosthesis Design | 4 | 2021 | 613 | 0.220 |
Why?
|
| Neoplastic Syndromes, Hereditary | 2 | 2022 | 84 | 0.210 |
Why?
|
| Carcinoma | 3 | 2013 | 284 | 0.210 |
Why?
|
| Psychomotor Disorders | 2 | 2016 | 30 | 0.210 |
Why?
|
| Sequence Analysis | 3 | 2020 | 50 | 0.210 |
Why?
|
| Genes, p53 | 3 | 2015 | 208 | 0.210 |
Why?
|
| Rats, Inbred BN | 1 | 2004 | 16 | 0.210 |
Why?
|
| Knowledge Bases | 1 | 2024 | 39 | 0.210 |
Why?
|
| Histone Acetyltransferases | 3 | 2020 | 226 | 0.210 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2020 | 498 | 0.210 |
Why?
|
| MutL Protein Homolog 1 | 3 | 2022 | 52 | 0.210 |
Why?
|
| Receptors, Metabotropic Glutamate | 2 | 2020 | 48 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2024 | 121 | 0.210 |
Why?
|
| Clinical Laboratory Services | 1 | 2024 | 19 | 0.210 |
Why?
|
| Trans-Activators | 6 | 2016 | 705 | 0.210 |
Why?
|
| Genes, Neoplasm | 3 | 2016 | 80 | 0.210 |
Why?
|
| Severe Combined Immunodeficiency | 2 | 2014 | 103 | 0.210 |
Why?
|
| Blood Pressure | 4 | 2022 | 1337 | 0.210 |
Why?
|
| Models, Cardiovascular | 1 | 2025 | 165 | 0.210 |
Why?
|
| Chromosomes | 3 | 2011 | 121 | 0.210 |
Why?
|
| DNA, Concatenated | 1 | 2003 | 5 | 0.210 |
Why?
|
| Minichromosome Maintenance Proteins | 2 | 2020 | 11 | 0.200 |
Why?
|
| Insulin | 4 | 2019 | 1146 | 0.200 |
Why?
|
| Wasps | 2 | 2018 | 9 | 0.200 |
Why?
|
| Diagnosis, Differential | 6 | 2021 | 1889 | 0.200 |
Why?
|
| Bacteriophage M13 | 4 | 1996 | 17 | 0.200 |
Why?
|
| Muscle Weakness | 2 | 2016 | 89 | 0.200 |
Why?
|
| Retroelements | 4 | 2014 | 42 | 0.200 |
Why?
|
| Myosins | 2 | 2015 | 42 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 6 | 2014 | 1232 | 0.200 |
Why?
|
| Quantitative Trait, Heritable | 3 | 2014 | 103 | 0.200 |
Why?
|
| Polycythemia Vera | 2 | 2014 | 41 | 0.200 |
Why?
|
| Receptors, Odorant | 3 | 2020 | 36 | 0.200 |
Why?
|
| Amino Acid Substitution | 7 | 2020 | 407 | 0.200 |
Why?
|
| Aorta | 2 | 2025 | 520 | 0.200 |
Why?
|
| Colorectal Neoplasms | 4 | 2022 | 622 | 0.200 |
Why?
|
| Models, Molecular | 8 | 2019 | 1058 | 0.200 |
Why?
|
| Eye Proteins | 3 | 2021 | 238 | 0.200 |
Why?
|
| Oncogenes | 3 | 2013 | 163 | 0.200 |
Why?
|
| Turkey | 6 | 2021 | 67 | 0.190 |
Why?
|
| RNA, Long Noncoding | 2 | 2023 | 220 | 0.190 |
Why?
|
| Gene Silencing | 2 | 2014 | 230 | 0.190 |
Why?
|
| Microbiota | 2 | 2019 | 443 | 0.190 |
Why?
|
| Health | 2 | 2020 | 34 | 0.190 |
Why?
|
| Transposition of Great Vessels | 1 | 2024 | 124 | 0.190 |
Why?
|
| Qa-SNARE Proteins | 1 | 2022 | 21 | 0.190 |
Why?
|
| Prospective Studies | 8 | 2024 | 6421 | 0.190 |
Why?
|
| Tongue Neoplasms | 2 | 2014 | 30 | 0.190 |
Why?
|
| Circulating Tumor DNA | 1 | 2023 | 42 | 0.190 |
Why?
|
| Blood Glucose | 3 | 2021 | 1105 | 0.190 |
Why?
|
| Mutagenesis | 3 | 2021 | 330 | 0.190 |
Why?
|
| Calcium Channels | 3 | 2019 | 146 | 0.190 |
Why?
|
| Myokymia | 1 | 2022 | 9 | 0.190 |
Why?
|
| Sequence Homology, Amino Acid | 8 | 2016 | 623 | 0.190 |
Why?
|
| Electrophoresis, Agar Gel | 4 | 1997 | 40 | 0.190 |
Why?
|
| Caliciviridae Infections | 1 | 2025 | 286 | 0.190 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2025 | 376 | 0.190 |
Why?
|
| Testis | 5 | 2020 | 398 | 0.190 |
Why?
|
| Tubulin | 3 | 2019 | 76 | 0.190 |
Why?
|
| Expressed Sequence Tags | 6 | 2010 | 80 | 0.190 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2022 | 42 | 0.190 |
Why?
|
| DNA Repair | 7 | 2020 | 576 | 0.190 |
Why?
|
| Cluster Analysis | 6 | 2018 | 417 | 0.180 |
Why?
|
| Cerebellar Ataxia | 2 | 2019 | 62 | 0.180 |
Why?
|
| CpG Islands | 7 | 2015 | 343 | 0.180 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 299 | 0.180 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2021 | 99 | 0.180 |
Why?
|
| Ethics, Medical | 3 | 2016 | 398 | 0.180 |
Why?
|
| Apyrase | 1 | 2022 | 21 | 0.180 |
Why?
|
| Factor VIII | 1 | 2022 | 51 | 0.180 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 1 | 2022 | 11 | 0.180 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2022 | 22 | 0.180 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2022 | 30 | 0.180 |
Why?
|
| Autoimmunity | 2 | 2021 | 175 | 0.180 |
Why?
|
| Glioblastoma | 4 | 2015 | 378 | 0.180 |
Why?
|
| Face | 3 | 2018 | 190 | 0.180 |
Why?
|
| Hemostatics | 1 | 2022 | 58 | 0.180 |
Why?
|
| Eukaryota | 1 | 2022 | 16 | 0.180 |
Why?
|
| Golgi Apparatus | 3 | 2021 | 93 | 0.180 |
Why?
|
| beta-Lactamases | 2 | 2016 | 216 | 0.180 |
Why?
|
| Genetic Therapy | 2 | 2020 | 718 | 0.180 |
Why?
|
| Norovirus | 1 | 2025 | 284 | 0.180 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2023 | 149 | 0.180 |
Why?
|
| Cryptosporidium | 1 | 2022 | 26 | 0.180 |
Why?
|
| Celiac Artery | 1 | 2022 | 31 | 0.180 |
Why?
|
| Sertoli-Leydig Cell Tumor | 1 | 2022 | 17 | 0.180 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 2 | 2018 | 400 | 0.180 |
Why?
|
| Cryptosporidium parvum | 1 | 2022 | 21 | 0.180 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 110 | 0.180 |
Why?
|
| Cryptosporidiosis | 1 | 2022 | 34 | 0.180 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2020 | 161 | 0.180 |
Why?
|
| GTPase-Activating Proteins | 3 | 2016 | 85 | 0.180 |
Why?
|
| Sensitivity and Specificity | 5 | 2020 | 2106 | 0.180 |
Why?
|
| Macropodidae | 2 | 2011 | 6 | 0.180 |
Why?
|
| Diabetic Nephropathies | 1 | 2023 | 113 | 0.180 |
Why?
|
| Cosmids | 4 | 1996 | 38 | 0.180 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2021 | 27 | 0.180 |
Why?
|
| Cattle | 4 | 2020 | 501 | 0.180 |
Why?
|
| Pectinidae | 1 | 2021 | 1 | 0.180 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 1 | 2021 | 10 | 0.180 |
Why?
|
| Access to Information | 2 | 2016 | 46 | 0.180 |
Why?
|
| DNA, Mitochondrial | 6 | 2023 | 232 | 0.180 |
Why?
|
| Feasibility Studies | 3 | 2023 | 813 | 0.180 |
Why?
|
| Neptune | 1 | 2021 | 4 | 0.180 |
Why?
|
| Coat Protein Complex I | 1 | 2021 | 12 | 0.180 |
Why?
|
| Prognosis | 7 | 2021 | 4894 | 0.180 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2016 | 188 | 0.180 |
Why?
|
| Herbivory | 2 | 2020 | 6 | 0.170 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2016 | 361 | 0.170 |
Why?
|
| Leber Congenital Amaurosis | 2 | 2011 | 34 | 0.170 |
Why?
|
| Genetic Fitness | 2 | 2018 | 34 | 0.170 |
Why?
|
| Health Level Seven | 1 | 2021 | 3 | 0.170 |
Why?
|
| Inflammation | 4 | 2024 | 1474 | 0.170 |
Why?
|
| Myelin P2 Protein | 2 | 2018 | 10 | 0.170 |
Why?
|
| Exosome Multienzyme Ribonuclease Complex | 1 | 2021 | 9 | 0.170 |
Why?
|
| Blood Platelets | 3 | 2024 | 316 | 0.170 |
Why?
|
| Sodium | 1 | 2022 | 280 | 0.170 |
Why?
|
| Demography | 2 | 2013 | 238 | 0.170 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2019 | 198 | 0.170 |
Why?
|
| Fibrinogen | 2 | 2022 | 166 | 0.170 |
Why?
|
| Ribonuclease III | 1 | 2022 | 100 | 0.170 |
Why?
|
| Wolffian Ducts | 1 | 2021 | 10 | 0.170 |
Why?
|
| AlkB Homolog 8, tRNA Methyltransferase | 1 | 2021 | 5 | 0.170 |
Why?
|
| Muscle Proteins | 3 | 2021 | 403 | 0.170 |
Why?
|
| Papio | 2 | 2019 | 57 | 0.170 |
Why?
|
| Physical Chromosome Mapping | 3 | 2015 | 55 | 0.170 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2021 | 6 | 0.170 |
Why?
|
| RNA Interference | 4 | 2018 | 495 | 0.170 |
Why?
|
| Immunologic Memory | 2 | 2020 | 194 | 0.170 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2021 | 49 | 0.170 |
Why?
|
| Symbiosis | 2 | 2014 | 95 | 0.170 |
Why?
|
| Macaca | 3 | 2018 | 59 | 0.170 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2018 | 342 | 0.170 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2016 | 325 | 0.170 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2023 | 220 | 0.170 |
Why?
|
| Dementia | 1 | 2026 | 429 | 0.170 |
Why?
|
| Chromosomal Proteins, Non-Histone | 3 | 2017 | 210 | 0.170 |
Why?
|
| Thysanoptera | 1 | 2020 | 4 | 0.170 |
Why?
|
| Life History Traits | 1 | 2020 | 5 | 0.170 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 46 | 0.170 |
Why?
|
| Moths | 2 | 2018 | 17 | 0.170 |
Why?
|
| Pancreatitis | 1 | 2022 | 137 | 0.170 |
Why?
|
| Workflow | 3 | 2017 | 140 | 0.170 |
Why?
|
| Human Migration | 1 | 2020 | 12 | 0.170 |
Why?
|
| Venous Thrombosis | 2 | 2013 | 173 | 0.170 |
Why?
|
| Consensus | 1 | 2023 | 528 | 0.160 |
Why?
|
| Hypertension | 4 | 2016 | 1352 | 0.160 |
Why?
|
| Myosin Heavy Chains | 2 | 2017 | 75 | 0.160 |
Why?
|
| Radiography | 7 | 2018 | 749 | 0.160 |
Why?
|
| Synaptic Transmission | 2 | 2020 | 323 | 0.160 |
Why?
|
| Penetrance | 4 | 2023 | 109 | 0.160 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 19 | 0.160 |
Why?
|
| Quality Control | 4 | 2021 | 115 | 0.160 |
Why?
|
| Aortography | 2 | 2018 | 151 | 0.160 |
Why?
|
| Body Mass Index | 4 | 2019 | 1676 | 0.160 |
Why?
|
| Hymenoptera | 1 | 2020 | 6 | 0.160 |
Why?
|
| Myxomycetes | 1 | 2020 | 3 | 0.160 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2020 | 30 | 0.160 |
Why?
|
| Insulin Resistance | 1 | 2025 | 683 | 0.160 |
Why?
|
| Polyketide Synthases | 1 | 2020 | 6 | 0.160 |
Why?
|
| Cytoskeletal Proteins | 3 | 2020 | 267 | 0.160 |
Why?
|
| DNA Helicases | 4 | 2023 | 234 | 0.160 |
Why?
|
| Leukemia | 1 | 2023 | 373 | 0.160 |
Why?
|
| Zebrafish Proteins | 2 | 2019 | 132 | 0.160 |
Why?
|
| Genomic Imprinting | 2 | 2019 | 123 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2019 | 96 | 0.160 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2020 | 32 | 0.160 |
Why?
|
| Subclavian Artery | 2 | 2021 | 64 | 0.160 |
Why?
|
| Genetic Techniques | 4 | 2003 | 96 | 0.160 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 192 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 810 | 0.160 |
Why?
|
| Mice, Knockout | 8 | 2020 | 3816 | 0.160 |
Why?
|
| Healthy Volunteers | 2 | 2017 | 150 | 0.160 |
Why?
|
| Genes, Homeobox | 2 | 2019 | 61 | 0.160 |
Why?
|
| Independent Living | 1 | 2020 | 66 | 0.160 |
Why?
|
| Biopsy | 2 | 2021 | 1237 | 0.160 |
Why?
|
| Aphids | 2 | 2010 | 12 | 0.160 |
Why?
|
| Biodiversity | 2 | 2022 | 75 | 0.160 |
Why?
|
| Organizational Case Studies | 1 | 2019 | 24 | 0.160 |
Why?
|
| Reference Values | 1 | 2021 | 678 | 0.160 |
Why?
|
| Ulcer | 1 | 2020 | 51 | 0.160 |
Why?
|
| Lissencephaly | 1 | 2019 | 10 | 0.160 |
Why?
|
| Prader-Willi Syndrome | 2 | 2017 | 62 | 0.160 |
Why?
|
| Histidine | 2 | 2022 | 69 | 0.150 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2019 | 32 | 0.150 |
Why?
|
| Hip Dislocation | 1 | 2020 | 36 | 0.150 |
Why?
|
| Angiolipoma | 1 | 2019 | 1 | 0.150 |
Why?
|
| Antigens, Neoplasm | 2 | 2021 | 398 | 0.150 |
Why?
|
| Mastectomy, Modified Radical | 1 | 2019 | 7 | 0.150 |
Why?
|
| Arabs | 2 | 2016 | 29 | 0.150 |
Why?
|
| Neoplasm Invasiveness | 3 | 2020 | 628 | 0.150 |
Why?
|
| Conservative Treatment | 1 | 2020 | 46 | 0.150 |
Why?
|
| Ependymoma | 1 | 2021 | 154 | 0.150 |
Why?
|
| Metalloendopeptidases | 2 | 2017 | 101 | 0.150 |
Why?
|
| Population Density | 5 | 2021 | 31 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2026 | 770 | 0.150 |
Why?
|
| Carcinoma, Ductal | 1 | 2019 | 12 | 0.150 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 251 | 0.150 |
Why?
|
| Transplant Recipients | 1 | 2021 | 227 | 0.150 |
Why?
|
| X Chromosome Inactivation | 2 | 2016 | 59 | 0.150 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 392 | 0.150 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2020 | 74 | 0.150 |
Why?
|
| Sodium-Glucose Transport Proteins | 1 | 2019 | 3 | 0.150 |
Why?
|
| Ultrasonography, Mammary | 1 | 2019 | 31 | 0.150 |
Why?
|
| Psychometrics | 1 | 2023 | 668 | 0.150 |
Why?
|
| von Willebrand Factor | 3 | 2022 | 190 | 0.150 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 346 | 0.150 |
Why?
|
| Autopsy | 2 | 2016 | 115 | 0.150 |
Why?
|
| Chromosomes, Human, Y | 4 | 2014 | 53 | 0.150 |
Why?
|
| Osteomyelitis | 1 | 2022 | 210 | 0.150 |
Why?
|
| Enterovirus | 1 | 2019 | 52 | 0.150 |
Why?
|
| Hematopoiesis | 2 | 2022 | 212 | 0.150 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2019 | 31 | 0.150 |
Why?
|
| Deoxyglucose | 1 | 2019 | 41 | 0.150 |
Why?
|
| DNA Damage | 2 | 2020 | 512 | 0.150 |
Why?
|
| Sirolimus | 2 | 2018 | 229 | 0.150 |
Why?
|
| Spleen | 2 | 2019 | 257 | 0.150 |
Why?
|
| Bone and Bones | 1 | 2021 | 307 | 0.150 |
Why?
|
| POU Domain Factors | 1 | 2018 | 8 | 0.150 |
Why?
|
| Cholangiocarcinoma | 1 | 2020 | 125 | 0.150 |
Why?
|
| Oligonucleotides | 5 | 1996 | 96 | 0.150 |
Why?
|
| Eye Abnormalities | 2 | 2016 | 103 | 0.150 |
Why?
|
| Adenosine Triphosphatases | 2 | 2017 | 189 | 0.150 |
Why?
|
| Gastritis | 1 | 2022 | 371 | 0.150 |
Why?
|
| Serine Endopeptidases | 1 | 2020 | 196 | 0.150 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2019 | 51 | 0.150 |
Why?
|
| Protozoan Proteins | 1 | 2020 | 130 | 0.150 |
Why?
|
| Herpesvirus 4, Human | 2 | 2021 | 641 | 0.150 |
Why?
|
| Carbon-Nitrogen Lyases | 1 | 1998 | 2 | 0.140 |
Why?
|
| Bile Duct Neoplasms | 1 | 2020 | 134 | 0.140 |
Why?
|
| RNA Helicases | 1 | 2019 | 75 | 0.140 |
Why?
|
| Clinical Protocols | 1 | 2020 | 228 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2024 | 254 | 0.140 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 58 | 0.140 |
Why?
|
| Paclitaxel | 1 | 2019 | 130 | 0.140 |
Why?
|
| Genes, pol | 3 | 1998 | 10 | 0.140 |
Why?
|
| Synaptotagmin I | 1 | 2018 | 9 | 0.140 |
Why?
|
| Insecticides | 2 | 2016 | 47 | 0.140 |
Why?
|
| Arthritis | 2 | 2019 | 83 | 0.140 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2021 | 273 | 0.140 |
Why?
|
| Receptors, Notch | 3 | 2015 | 201 | 0.140 |
Why?
|
| Risk Assessment | 4 | 2021 | 3680 | 0.140 |
Why?
|
| Cell Differentiation | 5 | 2020 | 1929 | 0.140 |
Why?
|
| Chromosome Breakage | 3 | 2008 | 156 | 0.140 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 170 | 0.140 |
Why?
|
| Time Factors | 10 | 2021 | 6187 | 0.140 |
Why?
|
| Molecular Structure | 2 | 2016 | 315 | 0.140 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2019 | 143 | 0.140 |
Why?
|
| Microarray Analysis | 1 | 2019 | 223 | 0.140 |
Why?
|
| Forecasting | 2 | 2019 | 353 | 0.140 |
Why?
|
| Cell Proliferation | 4 | 2020 | 2478 | 0.140 |
Why?
|
| STAT3 Transcription Factor | 1 | 2020 | 231 | 0.140 |
Why?
|
| Mastectomy, Segmental | 1 | 2018 | 39 | 0.140 |
Why?
|
| NAV1.8 Voltage-Gated Sodium Channel | 1 | 2018 | 5 | 0.140 |
Why?
|
| Pyrazoles | 1 | 2021 | 357 | 0.140 |
Why?
|
| Intermittent Claudication | 1 | 2018 | 49 | 0.140 |
Why?
|
| Karyotype | 2 | 2016 | 30 | 0.140 |
Why?
|
| Receptors, Interleukin | 1 | 2018 | 36 | 0.140 |
Why?
|
| Bayes Theorem | 4 | 2013 | 308 | 0.140 |
Why?
|
| Patella | 2 | 2015 | 27 | 0.140 |
Why?
|
| Margins of Excision | 1 | 2018 | 54 | 0.140 |
Why?
|
| HIV Reverse Transcriptase | 5 | 2002 | 17 | 0.140 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2018 | 130 | 0.140 |
Why?
|
| Primate Diseases | 1 | 2018 | 5 | 0.140 |
Why?
|
| Isoptera | 1 | 2018 | 4 | 0.140 |
Why?
|
| Blattellidae | 1 | 2018 | 5 | 0.140 |
Why?
|
| Axons | 3 | 2022 | 388 | 0.140 |
Why?
|
| Radiologists | 1 | 2018 | 55 | 0.140 |
Why?
|
| DNA Glycosylases | 2 | 2017 | 26 | 0.140 |
Why?
|
| Bacteria | 4 | 2019 | 536 | 0.140 |
Why?
|
| Solanum tuberosum | 1 | 2018 | 12 | 0.140 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 279 | 0.140 |
Why?
|
| Memory Disorders | 1 | 2020 | 204 | 0.140 |
Why?
|
| Francisella | 1 | 2017 | 4 | 0.140 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2018 | 29 | 0.140 |
Why?
|
| Exonucleases | 2 | 2015 | 27 | 0.140 |
Why?
|
| Introduced Species | 4 | 2020 | 22 | 0.140 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2017 | 11 | 0.140 |
Why?
|
| Host Specificity | 1 | 2018 | 17 | 0.140 |
Why?
|
| Cheirogaleidae | 1 | 2017 | 5 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 1257 | 0.140 |
Why?
|
| Agriculture | 1 | 2018 | 32 | 0.140 |
Why?
|
| Myosin Type V | 1 | 2017 | 9 | 0.140 |
Why?
|
| Loss of Heterozygosity | 3 | 2014 | 124 | 0.140 |
Why?
|
| Tularemia | 1 | 2017 | 13 | 0.140 |
Why?
|
| Lung Neoplasms | 3 | 2018 | 1543 | 0.140 |
Why?
|
| Pyrimidines | 1 | 2021 | 452 | 0.140 |
Why?
|
| Mycobiome | 1 | 2017 | 8 | 0.140 |
Why?
|
| Bone Development | 2 | 2020 | 58 | 0.140 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2018 | 113 | 0.140 |
Why?
|
| Retinal Degeneration | 2 | 2009 | 98 | 0.130 |
Why?
|
| Aortic Diseases | 1 | 2020 | 188 | 0.130 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 2 | 2016 | 22 | 0.130 |
Why?
|
| Spiders | 1 | 2017 | 5 | 0.130 |
Why?
|
| Primary Myelofibrosis | 1 | 2018 | 53 | 0.130 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2017 | 5 | 0.130 |
Why?
|
| Tissue Donors | 1 | 2021 | 502 | 0.130 |
Why?
|
| Receptors, HIV | 1 | 1997 | 3 | 0.130 |
Why?
|
| Corpus Callosum | 1 | 2018 | 109 | 0.130 |
Why?
|
| Gain of Function Mutation | 1 | 2018 | 117 | 0.130 |
Why?
|
| Fibromatosis, Gingival | 1 | 2017 | 4 | 0.130 |
Why?
|
| Ion Channel Gating | 1 | 2018 | 121 | 0.130 |
Why?
|
| Transcription Factor 4 | 1 | 2017 | 12 | 0.130 |
Why?
|
| Skin Neoplasms | 2 | 2015 | 899 | 0.130 |
Why?
|
| Feeding Behavior | 3 | 2020 | 705 | 0.130 |
Why?
|
| Fetus | 2 | 2018 | 572 | 0.130 |
Why?
|
| Hyperventilation | 1 | 2017 | 12 | 0.130 |
Why?
|
| Sheep | 1 | 2018 | 218 | 0.130 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 157 | 0.130 |
Why?
|
| Drosophila | 3 | 2012 | 794 | 0.130 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2017 | 91 | 0.130 |
Why?
|
| Neoadjuvant Therapy | 3 | 2025 | 394 | 0.130 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 172 | 0.130 |
Why?
|
| Receptors, Cytokine | 1 | 1997 | 66 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2017 | 111 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2015 | 108 | 0.130 |
Why?
|
| Cognition | 2 | 2018 | 813 | 0.130 |
Why?
|
| Receptors, KIR | 1 | 2017 | 10 | 0.130 |
Why?
|
| Immunity, Innate | 2 | 2020 | 405 | 0.130 |
Why?
|
| Adaptation, Physiological | 2 | 2018 | 252 | 0.130 |
Why?
|
| Molecular Epidemiology | 1 | 2017 | 145 | 0.130 |
Why?
|
| Mobius Syndrome | 1 | 2017 | 8 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2021 | 877 | 0.130 |
Why?
|
| Citric Acid Cycle | 1 | 2017 | 43 | 0.130 |
Why?
|
| Fungi | 1 | 2017 | 73 | 0.130 |
Why?
|
| Hemizygote | 1 | 2017 | 13 | 0.130 |
Why?
|
| Population Dynamics | 3 | 2014 | 29 | 0.130 |
Why?
|
| Cells, Cultured | 9 | 2019 | 2905 | 0.130 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2019 | 100 | 0.130 |
Why?
|
| Amino Acids | 2 | 2016 | 562 | 0.130 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2017 | 27 | 0.130 |
Why?
|
| Macaca fascicularis | 1 | 2017 | 81 | 0.130 |
Why?
|
| DNA Probes | 2 | 2005 | 118 | 0.130 |
Why?
|
| Receptors, Interleukin-6 | 2 | 2014 | 40 | 0.130 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2017 | 44 | 0.130 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2020 | 296 | 0.130 |
Why?
|
| Liddle Syndrome | 1 | 2016 | 4 | 0.130 |
Why?
|
| DNA, Intergenic | 2 | 2015 | 18 | 0.130 |
Why?
|
| Base Composition | 4 | 2014 | 71 | 0.130 |
Why?
|
| Wearable Electronic Devices | 1 | 2018 | 120 | 0.130 |
Why?
|
| Longevity | 1 | 2018 | 177 | 0.130 |
Why?
|
| Genes, env | 2 | 1998 | 10 | 0.130 |
Why?
|
| Forkhead Transcription Factors | 2 | 2016 | 372 | 0.130 |
Why?
|
| Recombination, Genetic | 5 | 2019 | 422 | 0.130 |
Why?
|
| Ceratitis capitata | 1 | 2016 | 4 | 0.130 |
Why?
|
| Exercise Therapy | 1 | 2018 | 169 | 0.130 |
Why?
|
| Small Molecule Libraries | 1 | 2018 | 132 | 0.130 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2018 | 175 | 0.130 |
Why?
|
| Nucleic Acid Hybridization | 7 | 2007 | 297 | 0.130 |
Why?
|
| Lymph Nodes | 2 | 2017 | 360 | 0.130 |
Why?
|
| Interferon Regulatory Factors | 1 | 2016 | 45 | 0.120 |
Why?
|
| Platelet Aggregation | 1 | 2017 | 104 | 0.120 |
Why?
|
| Virus Replication | 2 | 2022 | 597 | 0.120 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2020 | 155 | 0.120 |
Why?
|
| Acari | 1 | 2016 | 3 | 0.120 |
Why?
|
| Marfan Syndrome | 2 | 2016 | 146 | 0.120 |
Why?
|
| Decision Making | 2 | 2012 | 687 | 0.120 |
Why?
|
| Situs Inversus | 1 | 2016 | 26 | 0.120 |
Why?
|
| Ecotype | 1 | 2016 | 4 | 0.120 |
Why?
|
| Sudden Infant Death | 1 | 2016 | 37 | 0.120 |
Why?
|
| Chromosome Breakpoints | 4 | 2019 | 82 | 0.120 |
Why?
|
| Cytomegalovirus | 1 | 2018 | 258 | 0.120 |
Why?
|
| Hip Joint | 1 | 2016 | 50 | 0.120 |
Why?
|
| Bardet-Biedl Syndrome | 2 | 2014 | 36 | 0.120 |
Why?
|
| alpha-Galactosidase | 2 | 1997 | 20 | 0.120 |
Why?
|
| Disease | 2 | 2014 | 124 | 0.120 |
Why?
|
| Muscle, Skeletal | 2 | 2021 | 1005 | 0.120 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 102 | 0.120 |
Why?
|
| Autophagy | 1 | 2020 | 421 | 0.120 |
Why?
|
| 5'-Nucleotidase | 1 | 2016 | 23 | 0.120 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2019 | 216 | 0.120 |
Why?
|
| Triose-Phosphate Isomerase | 1 | 1996 | 7 | 0.120 |
Why?
|
| Smell | 2 | 2019 | 105 | 0.120 |
Why?
|
| Ubiquitination | 1 | 2017 | 169 | 0.120 |
Why?
|
| Feeding and Eating Disorders | 1 | 2017 | 71 | 0.120 |
Why?
|
| Tandem Repeat Sequences | 1 | 2016 | 35 | 0.120 |
Why?
|
| Gene Flow | 3 | 2020 | 14 | 0.120 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2016 | 31 | 0.120 |
Why?
|
| Ectoparasitic Infestations | 1 | 2016 | 7 | 0.120 |
Why?
|
| Death, Sudden | 1 | 2016 | 45 | 0.120 |
Why?
|
| Bedbugs | 1 | 2016 | 7 | 0.120 |
Why?
|
| SOX9 Transcription Factor | 1 | 2017 | 89 | 0.120 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2016 | 51 | 0.120 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 2015 | 2 | 0.120 |
Why?
|
| Health Insurance Portability and Accountability Act | 2 | 2006 | 21 | 0.120 |
Why?
|
| Anxiety | 2 | 2013 | 1001 | 0.120 |
Why?
|
| Arachnida | 1 | 2015 | 2 | 0.120 |
Why?
|
| Computer Graphics | 1 | 2016 | 40 | 0.120 |
Why?
|
| Chordata, Nonvertebrate | 1 | 2015 | 4 | 0.120 |
Why?
|
| Geminin | 1 | 2015 | 7 | 0.120 |
Why?
|
| Polyhydramnios | 1 | 2016 | 52 | 0.120 |
Why?
|
| Fatal Outcome | 4 | 2020 | 362 | 0.120 |
Why?
|
| BRCA1 Protein | 2 | 2024 | 82 | 0.120 |
Why?
|
| Tenascin | 1 | 2016 | 33 | 0.120 |
Why?
|
| Calmodulin-Binding Proteins | 2 | 2017 | 64 | 0.120 |
Why?
|
| Osteopetrosis | 2 | 2013 | 15 | 0.120 |
Why?
|
| Tibial Fractures | 1 | 2016 | 65 | 0.120 |
Why?
|
| Endoplasmic Reticulum | 3 | 2025 | 210 | 0.120 |
Why?
|
| Sezary Syndrome | 1 | 2015 | 13 | 0.120 |
Why?
|
| T-Lymphocytes | 2 | 2015 | 1711 | 0.120 |
Why?
|
| Virion | 1 | 1996 | 116 | 0.120 |
Why?
|
| Sesquiterpenes | 1 | 2015 | 26 | 0.120 |
Why?
|
| Transposases | 1 | 2016 | 44 | 0.120 |
Why?
|
| Duodenal Neoplasms | 1 | 2016 | 26 | 0.120 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2016 | 79 | 0.120 |
Why?
|
| Codon, Initiator | 2 | 2013 | 8 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2015 | 27 | 0.120 |
Why?
|
| Hylobates | 2 | 2014 | 10 | 0.120 |
Why?
|
| Janus Kinase 2 | 2 | 2014 | 138 | 0.120 |
Why?
|
| Aneurysm | 1 | 2016 | 66 | 0.120 |
Why?
|
| Brain Edema | 1 | 2016 | 66 | 0.120 |
Why?
|
| 5' Untranslated Regions | 2 | 2013 | 57 | 0.120 |
Why?
|
| Functional Laterality | 1 | 2016 | 180 | 0.120 |
Why?
|
| Genetic Load | 1 | 2015 | 5 | 0.120 |
Why?
|
| Metagenome | 3 | 2015 | 142 | 0.120 |
Why?
|
| Cytomegalovirus Infections | 1 | 2018 | 220 | 0.120 |
Why?
|
| Central Nervous System | 1 | 2017 | 277 | 0.120 |
Why?
|
| Texas | 3 | 2026 | 3626 | 0.120 |
Why?
|
| Klippel-Feil Syndrome | 1 | 2015 | 9 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2016 | 58 | 0.120 |
Why?
|
| Head and Neck Neoplasms | 2 | 2011 | 633 | 0.120 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 1995 | 20 | 0.120 |
Why?
|
| Cholesterol, HDL | 2 | 2017 | 393 | 0.120 |
Why?
|
| RNA, Transfer | 2 | 2014 | 67 | 0.120 |
Why?
|
| Phosphorylation | 4 | 2021 | 1577 | 0.120 |
Why?
|
| NADP Transhydrogenase, AB-Specific | 1 | 2015 | 4 | 0.120 |
Why?
|
| Biological Specimen Banks | 1 | 2016 | 63 | 0.120 |
Why?
|
| Chloride Channels | 1 | 2015 | 56 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 767 | 0.110 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2016 | 58 | 0.110 |
Why?
|
| Diptera | 1 | 2015 | 19 | 0.110 |
Why?
|
| Polyneuropathies | 1 | 2015 | 31 | 0.110 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2016 | 112 | 0.110 |
Why?
|
| C-Reactive Protein | 2 | 2017 | 444 | 0.110 |
Why?
|
| Orofaciodigital Syndromes | 1 | 2015 | 6 | 0.110 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2015 | 98 | 0.110 |
Why?
|
| Myelin Proteins | 1 | 2015 | 78 | 0.110 |
Why?
|
| Chondrodysplasia Punctata | 1 | 2015 | 15 | 0.110 |
Why?
|
| Steroid Isomerases | 1 | 2015 | 8 | 0.110 |
Why?
|
| Congenital Microtia | 1 | 2015 | 26 | 0.110 |
Why?
|
| Aortic Aneurysm | 1 | 2018 | 221 | 0.110 |
Why?
|
| Diploidy | 1 | 2015 | 40 | 0.110 |
Why?
|
| Histidine Ammonia-Lyase | 1 | 2015 | 4 | 0.110 |
Why?
|
| Robotics | 2 | 1998 | 102 | 0.110 |
Why?
|
| Cytokines | 2 | 2020 | 1335 | 0.110 |
Why?
|
| Globins | 1 | 1995 | 20 | 0.110 |
Why?
|
| Troponin T | 1 | 2017 | 255 | 0.110 |
Why?
|
| Phospholipases A2 | 1 | 2015 | 30 | 0.110 |
Why?
|
| Hypogonadism | 2 | 2019 | 324 | 0.110 |
Why?
|
| Hemostasis | 2 | 2013 | 76 | 0.110 |
Why?
|
| Surveys and Questionnaires | 3 | 2022 | 4001 | 0.110 |
Why?
|
| Carcinoma, Papillary | 1 | 2015 | 92 | 0.110 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 2016 | 152 | 0.110 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2018 | 292 | 0.110 |
Why?
|
| tau Proteins | 1 | 2017 | 258 | 0.110 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2014 | 27 | 0.110 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2015 | 45 | 0.110 |
Why?
|
| Antihypertensive Agents | 1 | 2018 | 419 | 0.110 |
Why?
|
| Hypopituitarism | 1 | 2015 | 18 | 0.110 |
Why?
|
| Rubella | 1 | 2014 | 18 | 0.110 |
Why?
|
| Chickenpox | 1 | 2014 | 22 | 0.110 |
Why?
|
| Minisatellite Repeats | 1 | 1995 | 43 | 0.110 |
Why?
|
| Fractures, Bone | 1 | 2017 | 210 | 0.110 |
Why?
|
| Skin | 2 | 2016 | 543 | 0.110 |
Why?
|
| De Lange Syndrome | 1 | 2015 | 44 | 0.110 |
Why?
|
| HeLa Cells | 3 | 2013 | 698 | 0.110 |
Why?
|
| Parkinsonian Disorders | 1 | 2016 | 79 | 0.110 |
Why?
|
| Fetal Hemoglobin | 1 | 2014 | 27 | 0.110 |
Why?
|
| Substrate Specificity | 5 | 2016 | 286 | 0.110 |
Why?
|
| Bacterial Proteins | 3 | 2016 | 938 | 0.110 |
Why?
|
| beta-Thalassemia | 1 | 1995 | 26 | 0.110 |
Why?
|
| Homocystinuria | 1 | 2015 | 26 | 0.110 |
Why?
|
| Genome, Archaeal | 1 | 2014 | 6 | 0.110 |
Why?
|
| Microsatellite Instability | 4 | 2018 | 38 | 0.110 |
Why?
|
| Lymphopenia | 1 | 2014 | 34 | 0.110 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2014 | 7 | 0.110 |
Why?
|
| Leprosy, Tuberculoid | 1 | 2014 | 7 | 0.110 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2015 | 51 | 0.110 |
Why?
|
| Pituitary Gland | 1 | 2015 | 75 | 0.110 |
Why?
|
| Blepharoptosis | 2 | 2012 | 67 | 0.110 |
Why?
|
| DNA Polymerase II | 1 | 2014 | 19 | 0.110 |
Why?
|
| Hypophosphatemia | 1 | 2014 | 9 | 0.110 |
Why?
|
| Receptors, Lipoprotein | 1 | 2014 | 10 | 0.110 |
Why?
|
| Molluscum Contagiosum | 1 | 2014 | 11 | 0.110 |
Why?
|
| Mortality | 1 | 2016 | 258 | 0.110 |
Why?
|
| Nephrocalcinosis | 1 | 2014 | 9 | 0.110 |
Why?
|
| Phosphoglucomutase | 1 | 2014 | 7 | 0.110 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2019 | 363 | 0.110 |
Why?
|
| Epidermodysplasia Verruciformis | 1 | 2014 | 13 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2025 | 3816 | 0.110 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2015 | 43 | 0.110 |
Why?
|
| Caenorhabditis elegans | 4 | 2023 | 253 | 0.110 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2014 | 16 | 0.110 |
Why?
|
| Cardiomyopathies | 2 | 2016 | 515 | 0.110 |
Why?
|
| Rumen | 1 | 2014 | 13 | 0.110 |
Why?
|
| Sheep, Domestic | 1 | 2014 | 17 | 0.110 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2014 | 10 | 0.110 |
Why?
|
| Telomere-Binding Proteins | 1 | 2014 | 45 | 0.110 |
Why?
|
| Azoospermia | 1 | 2015 | 54 | 0.110 |
Why?
|
| Cell Movement | 3 | 2026 | 871 | 0.110 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 1994 | 13 | 0.110 |
Why?
|
| Medication Adherence | 1 | 2018 | 332 | 0.110 |
Why?
|
| Lipomatosis | 1 | 2014 | 15 | 0.110 |
Why?
|
| Noonan Syndrome | 1 | 2014 | 31 | 0.110 |
Why?
|
| Mucous Membrane | 1 | 2014 | 89 | 0.110 |
Why?
|
| Glycosylation | 2 | 2025 | 126 | 0.110 |
Why?
|
| Phosphotransferases | 1 | 2014 | 33 | 0.110 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 358 | 0.100 |
Why?
|
| Anophthalmos | 1 | 2014 | 23 | 0.100 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 341 | 0.100 |
Why?
|
| Population Growth | 1 | 2013 | 5 | 0.100 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2014 | 30 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2014 | 87 | 0.100 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2014 | 41 | 0.100 |
Why?
|
| Dancing | 1 | 2014 | 9 | 0.100 |
Why?
|
| Apolipoproteins B | 2 | 2026 | 144 | 0.100 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 851 | 0.100 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2014 | 11 | 0.100 |
Why?
|
| Nails, Malformed | 1 | 2013 | 7 | 0.100 |
Why?
|
| Vocal Cord Paralysis | 1 | 2015 | 66 | 0.100 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2014 | 82 | 0.100 |
Why?
|
| Models, Theoretical | 2 | 2013 | 363 | 0.100 |
Why?
|
| Genome Size | 3 | 2020 | 13 | 0.100 |
Why?
|
| Granuloma | 1 | 2014 | 60 | 0.100 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2014 | 22 | 0.100 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2014 | 38 | 0.100 |
Why?
|
| Dictyostelium | 1 | 2015 | 117 | 0.100 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2014 | 28 | 0.100 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2016 | 323 | 0.100 |
Why?
|
| Virus Diseases | 1 | 2016 | 284 | 0.100 |
Why?
|
| COUP Transcription Factor I | 1 | 2014 | 54 | 0.100 |
Why?
|
| Bone Marrow Diseases | 1 | 2014 | 45 | 0.100 |
Why?
|
| Refsum Disease | 1 | 2013 | 4 | 0.100 |
Why?
|
| Hydroxyurea | 1 | 2014 | 86 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2015 | 256 | 0.100 |
Why?
|
| Gammaproteobacteria | 1 | 2014 | 21 | 0.100 |
Why?
|
| Granulocytes | 1 | 2014 | 68 | 0.100 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 2013 | 38 | 0.100 |
Why?
|
| Smoking | 3 | 2014 | 923 | 0.100 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2017 | 493 | 0.100 |
Why?
|
| Uniparental Disomy | 1 | 2014 | 43 | 0.100 |
Why?
|
| Disease Progression | 3 | 2017 | 2207 | 0.100 |
Why?
|
| Cataract | 1 | 2015 | 151 | 0.100 |
Why?
|
| Macular Degeneration | 1 | 2015 | 90 | 0.100 |
Why?
|
| Family Health | 5 | 2015 | 243 | 0.100 |
Why?
|
| Physical Fitness | 1 | 2014 | 90 | 0.100 |
Why?
|
| Restriction Mapping | 8 | 2000 | 168 | 0.100 |
Why?
|
| Rett Syndrome | 1 | 2016 | 229 | 0.100 |
Why?
|
| Viral Proteins | 1 | 1995 | 339 | 0.100 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 102 | 0.100 |
Why?
|
| Central Nervous System Diseases | 1 | 2014 | 97 | 0.100 |
Why?
|
| Peripheral Arterial Disease | 1 | 2017 | 318 | 0.100 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2013 | 14 | 0.100 |
Why?
|
| Cleidocranial Dysplasia | 1 | 2013 | 6 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 6 | 2020 | 4701 | 0.100 |
Why?
|
| Liver Neoplasms | 3 | 2015 | 1395 | 0.100 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2014 | 93 | 0.100 |
Why?
|
| Myofibromatosis | 1 | 2013 | 10 | 0.100 |
Why?
|
| Severity of Illness Index | 5 | 2022 | 3031 | 0.100 |
Why?
|
| Blood Cells | 1 | 2013 | 53 | 0.100 |
Why?
|
| Anxiety Disorders | 1 | 2020 | 730 | 0.100 |
Why?
|
| Flavoproteins | 1 | 2013 | 21 | 0.100 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 4 | 2018 | 174 | 0.100 |
Why?
|
| RNA Editing | 2 | 2014 | 32 | 0.100 |
Why?
|
| Melopsittacus | 1 | 2012 | 4 | 0.100 |
Why?
|
| Wnt1 Protein | 1 | 2013 | 71 | 0.100 |
Why?
|
| HEK293 Cells | 4 | 2017 | 811 | 0.100 |
Why?
|
| Glycoside Hydrolases | 1 | 2012 | 16 | 0.100 |
Why?
|
| Pan troglodytes | 3 | 2012 | 71 | 0.100 |
Why?
|
| Carcinoma in Situ | 1 | 2013 | 69 | 0.100 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2015 | 182 | 0.100 |
Why?
|
| Neurons | 5 | 2026 | 2018 | 0.100 |
Why?
|
| Internationality | 1 | 2013 | 128 | 0.100 |
Why?
|
| Proline | 1 | 2013 | 78 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2014 | 1005 | 0.100 |
Why?
|
| Ginsenosides | 1 | 2012 | 16 | 0.100 |
Why?
|
| Muscular Dystrophies | 5 | 1995 | 50 | 0.100 |
Why?
|
| Hypertriglyceridemia | 1 | 2014 | 118 | 0.100 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 298 | 0.100 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2018 | 974 | 0.100 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2012 | 20 | 0.100 |
Why?
|
| ras Proteins | 4 | 2014 | 147 | 0.100 |
Why?
|
| DNA, Recombinant | 3 | 1989 | 71 | 0.100 |
Why?
|
| Genetic Vectors | 6 | 2012 | 902 | 0.100 |
Why?
|
| Nucleoside Transport Proteins | 1 | 2012 | 6 | 0.090 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 3 | 2017 | 83 | 0.090 |
Why?
|
| Ectodermal Dysplasia | 1 | 2013 | 48 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 1 | 2016 | 289 | 0.090 |
Why?
|
| Osteosclerosis | 1 | 2012 | 11 | 0.090 |
Why?
|
| Ampicillin | 1 | 2012 | 59 | 0.090 |
Why?
|
| Autoimmune Diseases | 1 | 2015 | 264 | 0.090 |
Why?
|
| Strongylocentrotus purpuratus | 1 | 2012 | 5 | 0.090 |
Why?
|
| Colitis | 1 | 2014 | 164 | 0.090 |
Why?
|
| Olfactory Receptor Neurons | 1 | 2012 | 26 | 0.090 |
Why?
|
| RNA, Ribosomal, 18S | 2 | 2025 | 20 | 0.090 |
Why?
|
| Urinary Bladder | 1 | 2014 | 219 | 0.090 |
Why?
|
| Serine | 1 | 2013 | 161 | 0.090 |
Why?
|
| Papillomavirus Infections | 2 | 2014 | 383 | 0.090 |
Why?
|
| Enterococcus faecium | 1 | 2012 | 19 | 0.090 |
Why?
|
| Computer Simulation | 3 | 2025 | 676 | 0.090 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 750 | 0.090 |
Why?
|
| Genetic Engineering | 3 | 2005 | 161 | 0.090 |
Why?
|
| Chromosome Segregation | 3 | 2017 | 68 | 0.090 |
Why?
|
| von Willebrand Diseases | 1 | 2013 | 55 | 0.090 |
Why?
|
| Prevalence | 4 | 2023 | 2684 | 0.090 |
Why?
|
| Retina | 2 | 2015 | 452 | 0.090 |
Why?
|
| Epistasis, Genetic | 1 | 2012 | 97 | 0.090 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2012 | 9 | 0.090 |
Why?
|
| Behavior, Animal | 1 | 2015 | 486 | 0.090 |
Why?
|
| Genetic Carrier Screening | 5 | 1995 | 69 | 0.090 |
Why?
|
| Yaws | 1 | 2012 | 5 | 0.090 |
Why?
|
| Lung | 2 | 2025 | 1547 | 0.090 |
Why?
|
| Telomere | 4 | 2017 | 220 | 0.090 |
Why?
|
| Age Factors | 5 | 2020 | 2835 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1995 | 599 | 0.090 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2012 | 850 | 0.090 |
Why?
|
| Kidney | 4 | 2023 | 1283 | 0.090 |
Why?
|
| Parents | 3 | 2023 | 1102 | 0.090 |
Why?
|
| Cerebellum | 4 | 2020 | 445 | 0.090 |
Why?
|
| Treponema pallidum | 1 | 2012 | 48 | 0.090 |
Why?
|
| Mouth Neoplasms | 1 | 2013 | 93 | 0.090 |
Why?
|
| Pediatric Obesity | 1 | 2017 | 411 | 0.090 |
Why?
|
| Neural Conduction | 3 | 2018 | 83 | 0.090 |
Why?
|
| Chromosomes, Mammalian | 3 | 2011 | 40 | 0.090 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2011 | 16 | 0.090 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2013 | 191 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2016 | 484 | 0.090 |
Why?
|
| Larva | 3 | 2017 | 249 | 0.090 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2011 | 12 | 0.090 |
Why?
|
| Academies and Institutes | 1 | 2012 | 80 | 0.090 |
Why?
|
| Endoplasmic Reticulum Stress | 3 | 2018 | 125 | 0.090 |
Why?
|
| Treponema | 1 | 2011 | 7 | 0.090 |
Why?
|
| Reproduction | 3 | 2020 | 213 | 0.090 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2013 | 177 | 0.090 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2012 | 53 | 0.090 |
Why?
|
| F-Box Proteins | 1 | 2011 | 32 | 0.090 |
Why?
|
| Principal Component Analysis | 3 | 2019 | 153 | 0.090 |
Why?
|
| Twins, Dizygotic | 1 | 2011 | 45 | 0.090 |
Why?
|
| Oligonucleotide Probes | 4 | 2025 | 85 | 0.090 |
Why?
|
| Stomach Neoplasms | 1 | 2017 | 576 | 0.090 |
Why?
|
| Thymus Gland | 1 | 2011 | 104 | 0.090 |
Why?
|
| Colon | 1 | 2014 | 356 | 0.090 |
Why?
|
| Pongo abelii | 1 | 2011 | 3 | 0.090 |
Why?
|
| Pongo pygmaeus | 1 | 2011 | 6 | 0.090 |
Why?
|
| Glycoproteins | 2 | 2026 | 346 | 0.090 |
Why?
|
| Protein Stability | 3 | 2017 | 165 | 0.090 |
Why?
|
| Retroviridae | 2 | 1997 | 182 | 0.090 |
Why?
|
| Ciliary Motility Disorders | 1 | 2011 | 11 | 0.090 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 1 | 2011 | 18 | 0.080 |
Why?
|
| Syphilis | 1 | 2012 | 95 | 0.080 |
Why?
|
| Feces | 3 | 2019 | 721 | 0.080 |
Why?
|
| Coloboma | 2 | 2014 | 40 | 0.080 |
Why?
|
| Levodopa | 1 | 2011 | 91 | 0.080 |
Why?
|
| Registries | 1 | 2018 | 1605 | 0.080 |
Why?
|
| Proteomics | 3 | 2023 | 610 | 0.080 |
Why?
|
| Receptor, Notch1 | 1 | 2011 | 77 | 0.080 |
Why?
|
| Mental Disorders | 1 | 2018 | 890 | 0.080 |
Why?
|
| Gardnerella vaginalis | 1 | 2010 | 5 | 0.080 |
Why?
|
| Receptors, Somatostatin | 1 | 2011 | 55 | 0.080 |
Why?
|
| T-Box Domain Proteins | 2 | 2022 | 120 | 0.080 |
Why?
|
| Logistic Models | 2 | 2013 | 1799 | 0.080 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2009 | 169 | 0.080 |
Why?
|
| Chromatin | 5 | 2016 | 504 | 0.080 |
Why?
|
| Embryo, Mammalian | 4 | 2016 | 400 | 0.080 |
Why?
|
| Vaginosis, Bacterial | 1 | 2010 | 18 | 0.080 |
Why?
|
| Genetic Drift | 3 | 2016 | 20 | 0.080 |
Why?
|
| Anemia, Sickle Cell | 1 | 2014 | 325 | 0.080 |
Why?
|
| Rhabdoid Tumor | 1 | 2011 | 49 | 0.080 |
Why?
|
| Solutions | 1 | 2010 | 50 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 192 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 4 | 2014 | 714 | 0.080 |
Why?
|
| Environment | 1 | 2011 | 148 | 0.080 |
Why?
|
| Nucleotides | 2 | 2022 | 88 | 0.080 |
Why?
|
| Pregnancy Outcome | 1 | 2013 | 615 | 0.080 |
Why?
|
| Biotechnology | 2 | 2005 | 59 | 0.080 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2016 | 575 | 0.080 |
Why?
|
| Multiple Myeloma | 1 | 2012 | 187 | 0.080 |
Why?
|
| Population | 2 | 2013 | 22 | 0.080 |
Why?
|
| Hydrolysis | 3 | 2016 | 139 | 0.080 |
Why?
|
| Crossing Over, Genetic | 3 | 2020 | 53 | 0.080 |
Why?
|
| Islets of Langerhans | 2 | 2021 | 161 | 0.080 |
Why?
|
| Heart | 1 | 2014 | 661 | 0.080 |
Why?
|
| Cadaver | 1 | 2010 | 117 | 0.080 |
Why?
|
| Mutagenesis, Insertional | 4 | 2014 | 151 | 0.080 |
Why?
|
| Glutamine | 2 | 2022 | 204 | 0.080 |
Why?
|
| Fimbriae, Bacterial | 1 | 2009 | 39 | 0.080 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 1796 | 0.080 |
Why?
|
| Body Size | 1 | 2009 | 58 | 0.080 |
Why?
|
| Enterobacteriaceae | 1 | 2009 | 41 | 0.080 |
Why?
|
| Multiple Sclerosis | 1 | 2013 | 391 | 0.080 |
Why?
|
| Streptococcus | 1 | 2009 | 64 | 0.070 |
Why?
|
| London | 2 | 2021 | 14 | 0.070 |
Why?
|
| Deafness | 2 | 2020 | 78 | 0.070 |
Why?
|
| Adhesins, Bacterial | 1 | 2009 | 72 | 0.070 |
Why?
|
| Pseudogenes | 3 | 2004 | 50 | 0.070 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2018 | 386 | 0.070 |
Why?
|
| Binding, Competitive | 1 | 1989 | 145 | 0.070 |
Why?
|
| Vaccination | 1 | 2014 | 1041 | 0.070 |
Why?
|
| Protein Conformation | 3 | 2016 | 729 | 0.070 |
Why?
|
| Sequence Analysis, Protein | 1 | 2009 | 48 | 0.070 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 10 | 0.070 |
Why?
|
| Pulmonary Alveolar Proteinosis | 1 | 2008 | 6 | 0.070 |
Why?
|
| Autoantibodies | 2 | 2022 | 439 | 0.070 |
Why?
|
| Interspersed Repetitive Sequences | 3 | 2015 | 25 | 0.070 |
Why?
|
| LIM Domain Proteins | 2 | 2020 | 65 | 0.070 |
Why?
|
| Europe | 2 | 2009 | 366 | 0.070 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 14 | 0.070 |
Why?
|
| Intestines | 1 | 2012 | 589 | 0.070 |
Why?
|
| Connectin | 2 | 2019 | 28 | 0.070 |
Why?
|
| Saccharomyces cerevisiae | 3 | 1998 | 400 | 0.070 |
Why?
|
| Lymphocyte Activation | 4 | 2018 | 630 | 0.070 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2013 | 489 | 0.070 |
Why?
|
| Bone Marrow Transplantation | 2 | 2024 | 590 | 0.070 |
Why?
|
| Peptides | 3 | 2017 | 708 | 0.070 |
Why?
|
| Age of Onset | 3 | 2015 | 598 | 0.070 |
Why?
|
| Enterococcus faecalis | 1 | 2008 | 50 | 0.070 |
Why?
|
| Euchromatin | 3 | 2002 | 12 | 0.070 |
Why?
|
| Embryo, Nonmammalian | 2 | 2021 | 139 | 0.070 |
Why?
|
| Likelihood Functions | 3 | 2017 | 117 | 0.070 |
Why?
|
| Blindness | 1 | 2008 | 71 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2025 | 1484 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 4 | 2012 | 752 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2016 | 1076 | 0.070 |
Why?
|
| RNA, Small Interfering | 2 | 2021 | 667 | 0.070 |
Why?
|
| Neoplasm Grading | 2 | 2021 | 277 | 0.070 |
Why?
|
| Codon, Terminator | 2 | 2023 | 25 | 0.070 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 157 | 0.060 |
Why?
|
| Chromosome Duplication | 2 | 2019 | 147 | 0.060 |
Why?
|
| Immunophenotyping | 2 | 2018 | 330 | 0.060 |
Why?
|
| Host-Pathogen Interactions | 2 | 2025 | 253 | 0.060 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2018 | 65 | 0.060 |
Why?
|
| Influenza, Human | 1 | 2013 | 700 | 0.060 |
Why?
|
| Sea Urchins | 1 | 2006 | 7 | 0.060 |
Why?
|
| Recombinant Proteins | 4 | 2000 | 1323 | 0.060 |
Why?
|
| Energy Intake | 1 | 2009 | 498 | 0.060 |
Why?
|
| Saudi Arabia | 3 | 2011 | 41 | 0.060 |
Why?
|
| Ecosystem | 2 | 2020 | 91 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 992 | 0.060 |
Why?
|
| Transfection | 4 | 1997 | 962 | 0.060 |
Why?
|
| Cadherins | 2 | 2018 | 181 | 0.060 |
Why?
|
| Overweight | 1 | 2009 | 376 | 0.060 |
Why?
|
| Sample Size | 2 | 2021 | 86 | 0.060 |
Why?
|
| Chemoreceptor Cells | 2 | 2017 | 14 | 0.060 |
Why?
|
| Life Style | 1 | 2009 | 444 | 0.060 |
Why?
|
| Escherichia coli | 2 | 2012 | 983 | 0.060 |
Why?
|
| Platelet Count | 2 | 2017 | 139 | 0.060 |
Why?
|
| DNA Fingerprinting | 2 | 2004 | 107 | 0.060 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2017 | 121 | 0.060 |
Why?
|
| Genes, MHC Class II | 1 | 2006 | 11 | 0.060 |
Why?
|
| Genes, Bacterial | 3 | 2017 | 216 | 0.060 |
Why?
|
| Acute Disease | 2 | 2022 | 1151 | 0.060 |
Why?
|
| Kinetics | 3 | 2016 | 1087 | 0.060 |
Why?
|
| Ethics Committees, Research | 1 | 2006 | 29 | 0.060 |
Why?
|
| Disease Models, Animal | 6 | 2017 | 4664 | 0.060 |
Why?
|
| Embryonic Development | 2 | 2019 | 199 | 0.060 |
Why?
|
| Facial Asymmetry | 1 | 2005 | 17 | 0.060 |
Why?
|
| Genome, Mitochondrial | 2 | 2017 | 26 | 0.060 |
Why?
|
| Vagina | 2 | 2022 | 199 | 0.060 |
Why?
|
| Haploinsufficiency | 2 | 2021 | 263 | 0.060 |
Why?
|
| Epigenomics | 2 | 2021 | 183 | 0.060 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2005 | 11 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1998 | 325 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 1312 | 0.060 |
Why?
|
| Mass Spectrometry | 2 | 2017 | 362 | 0.060 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 2 | 2016 | 28 | 0.060 |
Why?
|
| Utah | 1 | 2005 | 83 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2021 | 976 | 0.060 |
Why?
|
| Research Subjects | 1 | 2006 | 54 | 0.060 |
Why?
|
| South Africa | 2 | 2020 | 100 | 0.060 |
Why?
|
| Ataxins | 1 | 2005 | 109 | 0.060 |
Why?
|
| Multiprotein Complexes | 2 | 2017 | 197 | 0.060 |
Why?
|
| Nucleotide Motifs | 2 | 2016 | 50 | 0.060 |
Why?
|
| Food, Genetically Modified | 1 | 2005 | 4 | 0.060 |
Why?
|
| Predictive Value of Tests | 4 | 2018 | 2298 | 0.060 |
Why?
|
| Yeasts | 1 | 2005 | 43 | 0.060 |
Why?
|
| Receptors, LDL | 1 | 2026 | 106 | 0.060 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2018 | 109 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2022 | 546 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 2 | 2020 | 304 | 0.060 |
Why?
|
| Vertebrates | 1 | 2005 | 36 | 0.060 |
Why?
|
| Mutant Proteins | 2 | 2018 | 111 | 0.060 |
Why?
|
| Microscopy, Confocal | 2 | 2018 | 340 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2017 | 291 | 0.060 |
Why?
|
| Selenoproteins | 2 | 2015 | 13 | 0.060 |
Why?
|
| Hydrodynamics | 1 | 2025 | 28 | 0.060 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2018 | 194 | 0.060 |
Why?
|
| Clone Cells | 1 | 2025 | 153 | 0.060 |
Why?
|
| Molecular Probes | 1 | 2005 | 26 | 0.060 |
Why?
|
| Cerebral Cortex | 2 | 2020 | 451 | 0.060 |
Why?
|
| Protein Transport | 2 | 2017 | 364 | 0.050 |
Why?
|
| Ethanolamine | 1 | 2024 | 8 | 0.050 |
Why?
|
| Animals, Genetically Modified | 2 | 2016 | 328 | 0.050 |
Why?
|
| 3' Untranslated Regions | 3 | 2012 | 155 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2018 | 116 | 0.050 |
Why?
|
| Trastuzumab | 1 | 2025 | 136 | 0.050 |
Why?
|
| Public Opinion | 1 | 2005 | 63 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 2 | 2014 | 22 | 0.050 |
Why?
|
| Heterochromatin | 2 | 2001 | 54 | 0.050 |
Why?
|
| Rickettsia typhi | 1 | 2004 | 12 | 0.050 |
Why?
|
| Protein Biosynthesis | 4 | 2014 | 575 | 0.050 |
Why?
|
| Glutamates | 1 | 2004 | 54 | 0.050 |
Why?
|
| Choline | 1 | 2024 | 51 | 0.050 |
Why?
|
| Protein Binding | 2 | 2019 | 1666 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2017 | 420 | 0.050 |
Why?
|
| Electrocardiography | 2 | 2021 | 974 | 0.050 |
Why?
|
| Biological Variation, Population | 1 | 2024 | 28 | 0.050 |
Why?
|
| Nodal Protein | 1 | 2024 | 28 | 0.050 |
Why?
|
| Receptors, Virus | 1 | 2024 | 95 | 0.050 |
Why?
|
| Binding Sites | 2 | 2019 | 1150 | 0.050 |
Why?
|
| Japan | 2 | 2014 | 166 | 0.050 |
Why?
|
| Rats, Mutant Strains | 2 | 2017 | 15 | 0.050 |
Why?
|
| Genetic Complementation Test | 2 | 2015 | 89 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 1415 | 0.050 |
Why?
|
| Automation | 1 | 2004 | 65 | 0.050 |
Why?
|
| Fragile X Syndrome | 2 | 1996 | 148 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2024 | 105 | 0.050 |
Why?
|
| NIH 3T3 Cells | 1 | 2023 | 91 | 0.050 |
Why?
|
| Receptors, Estrogen | 2 | 2024 | 726 | 0.050 |
Why?
|
| Telomerase | 2 | 2014 | 153 | 0.050 |
Why?
|
| Movement Disorders | 2 | 2018 | 218 | 0.050 |
Why?
|
| West Nile Fever | 1 | 2005 | 143 | 0.050 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2025 | 252 | 0.050 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2023 | 14 | 0.050 |
Why?
|
| Depression | 1 | 2012 | 1317 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2025 | 418 | 0.050 |
Why?
|
| Exercise | 1 | 2009 | 858 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2018 | 1498 | 0.050 |
Why?
|
| Proto-Oncogenes | 2 | 2008 | 37 | 0.050 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2023 | 79 | 0.050 |
Why?
|
| Postmenopause | 1 | 2024 | 136 | 0.050 |
Why?
|
| Research Design | 2 | 2005 | 717 | 0.050 |
Why?
|
| Aminopeptidases | 1 | 2023 | 15 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2025 | 3801 | 0.050 |
Why?
|
| Nitriles | 1 | 2024 | 161 | 0.050 |
Why?
|
| Autoanalysis | 2 | 1996 | 4 | 0.050 |
Why?
|
| Heart Failure | 1 | 2016 | 2313 | 0.050 |
Why?
|
| Gene Order | 2 | 2014 | 82 | 0.050 |
Why?
|
| Saccharomyces | 2 | 2017 | 9 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2003 | 48 | 0.050 |
Why?
|
| Triazoles | 1 | 2024 | 138 | 0.050 |
Why?
|
| Gestational Age | 2 | 2019 | 1212 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2019 | 136 | 0.050 |
Why?
|
| Hormones | 2 | 2014 | 163 | 0.050 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2026 | 243 | 0.050 |
Why?
|
| X-ray Repair Cross Complementing Protein 1 | 1 | 2022 | 19 | 0.050 |
Why?
|
| Forensic Medicine | 1 | 2002 | 10 | 0.050 |
Why?
|
| Arteries | 1 | 2024 | 210 | 0.050 |
Why?
|
| Gastroenteritis | 1 | 2025 | 308 | 0.050 |
Why?
|
| Plasma | 2 | 2014 | 103 | 0.050 |
Why?
|
| Factor VII | 1 | 2022 | 17 | 0.050 |
Why?
|
| HIV Envelope Protein gp120 | 2 | 2002 | 22 | 0.050 |
Why?
|
| Iran | 1 | 2023 | 97 | 0.050 |
Why?
|
| Crime | 1 | 2002 | 26 | 0.050 |
Why?
|
| Reverse Genetics | 1 | 2022 | 15 | 0.050 |
Why?
|
| Carboplatin | 1 | 2022 | 78 | 0.050 |
Why?
|
| Muscles | 2 | 2016 | 203 | 0.050 |
Why?
|
| Minority Groups | 1 | 2024 | 258 | 0.050 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2022 | 39 | 0.050 |
Why?
|
| ADAMTS13 Protein | 2 | 2013 | 65 | 0.050 |
Why?
|
| DNA Mismatch Repair | 1 | 2022 | 44 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2024 | 412 | 0.050 |
Why?
|
| Prefrontal Cortex | 1 | 2004 | 214 | 0.050 |
Why?
|
| Dysarthria | 1 | 2022 | 25 | 0.050 |
Why?
|
| A549 Cells | 1 | 2022 | 49 | 0.050 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2018 | 102 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2018 | 1231 | 0.050 |
Why?
|
| Benchmarking | 1 | 2022 | 135 | 0.040 |
Why?
|
| Egypt | 1 | 2021 | 29 | 0.040 |
Why?
|
| Nitrogen | 1 | 2022 | 120 | 0.040 |
Why?
|
| Paraplegia | 1 | 2022 | 87 | 0.040 |
Why?
|
| Metabolic Syndrome | 1 | 2025 | 366 | 0.040 |
Why?
|
| Retroviruses, Simian | 2 | 1992 | 3 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2023 | 325 | 0.040 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2003 | 156 | 0.040 |
Why?
|
| Receptor, trkB | 1 | 2021 | 23 | 0.040 |
Why?
|
| Calpain | 1 | 2021 | 43 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2023 | 655 | 0.040 |
Why?
|
| Immune Evasion | 1 | 2021 | 38 | 0.040 |
Why?
|
| Crime Victims | 1 | 2002 | 76 | 0.040 |
Why?
|
| Turner Syndrome | 2 | 2014 | 44 | 0.040 |
Why?
|
| Visual Acuity | 2 | 2015 | 529 | 0.040 |
Why?
|
| Subcutaneous Tissue | 1 | 2021 | 15 | 0.040 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 72 | 0.040 |
Why?
|
| Paternal Inheritance | 1 | 2021 | 10 | 0.040 |
Why?
|
| PAX8 Transcription Factor | 1 | 2021 | 15 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2021 | 111 | 0.040 |
Why?
|
| Bias | 1 | 2021 | 143 | 0.040 |
Why?
|
| Upper Extremity | 1 | 2021 | 52 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 2 | 2014 | 305 | 0.040 |
Why?
|
| Fossils | 1 | 2020 | 7 | 0.040 |
Why?
|
| Genetic Pleiotropy | 1 | 2021 | 25 | 0.040 |
Why?
|
| Cercopithecidae | 1 | 2020 | 8 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2021 | 26 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2021 | 40 | 0.040 |
Why?
|
| Triglycerides | 2 | 2014 | 605 | 0.040 |
Why?
|
| Food Chain | 1 | 2020 | 10 | 0.040 |
Why?
|
| Risk | 2 | 2014 | 729 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2025 | 802 | 0.040 |
Why?
|
| Crops, Agricultural | 1 | 2020 | 13 | 0.040 |
Why?
|
| Amines | 1 | 2020 | 35 | 0.040 |
Why?
|
| Peru | 1 | 2020 | 54 | 0.040 |
Why?
|
| AIDS Vaccines | 1 | 2000 | 31 | 0.040 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2020 | 38 | 0.040 |
Why?
|
| History, Ancient | 1 | 2020 | 53 | 0.040 |
Why?
|
| Atrioventricular Block | 1 | 2021 | 45 | 0.040 |
Why?
|
| Models, Immunological | 1 | 2020 | 36 | 0.040 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2020 | 8 | 0.040 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2020 | 8 | 0.040 |
Why?
|
| Cytidine Deaminase | 1 | 2020 | 31 | 0.040 |
Why?
|
| RNA, Neoplasm | 2 | 2015 | 127 | 0.040 |
Why?
|
| Metabolism | 1 | 2020 | 45 | 0.040 |
Why?
|
| Survival Rate | 2 | 2016 | 2131 | 0.040 |
Why?
|
| Models, Statistical | 2 | 2014 | 482 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2020 | 61 | 0.040 |
Why?
|
| Africa | 1 | 2020 | 140 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2000 | 68 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 316 | 0.040 |
Why?
|
| Sequence Homology | 2 | 2014 | 59 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2021 | 240 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 2008 | 236 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 157 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2000 | 184 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2020 | 247 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2022 | 312 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2000 | 156 | 0.040 |
Why?
|
| Quadriplegia | 1 | 2020 | 35 | 0.040 |
Why?
|
| Iron-Binding Proteins | 1 | 1999 | 25 | 0.040 |
Why?
|
| Polychondritis, Relapsing | 1 | 2019 | 3 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 2017 | 144 | 0.040 |
Why?
|
| Friedreich Ataxia | 1 | 1999 | 30 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2019 | 96 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 170 | 0.040 |
Why?
|
| Muscle Spasticity | 1 | 2020 | 52 | 0.040 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1999 | 72 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2015 | 1399 | 0.040 |
Why?
|
| Vision, Ocular | 1 | 2020 | 117 | 0.040 |
Why?
|
| CYS2-HIS2 Zinc Fingers | 1 | 2019 | 5 | 0.040 |
Why?
|
| Chemoradiotherapy, Adjuvant | 1 | 2019 | 30 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 382 | 0.040 |
Why?
|
| Blotting, Southern | 3 | 1997 | 203 | 0.040 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 1999 | 82 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 1996 | 79 | 0.040 |
Why?
|
| Pigmentation | 1 | 2019 | 35 | 0.040 |
Why?
|
| Ankyrins | 1 | 2020 | 96 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 73 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2021 | 411 | 0.040 |
Why?
|
| Antarctic Regions | 1 | 2019 | 8 | 0.040 |
Why?
|
| Hybridization, Genetic | 1 | 2019 | 20 | 0.040 |
Why?
|
| Perception | 1 | 2020 | 227 | 0.040 |
Why?
|
| Postmortem Changes | 1 | 2018 | 11 | 0.040 |
Why?
|
| Peroxidases | 1 | 2019 | 29 | 0.040 |
Why?
|
| Microtubules | 1 | 2019 | 129 | 0.040 |
Why?
|
| Immunoglobulin G | 2 | 2018 | 790 | 0.040 |
Why?
|
| Aotidae | 1 | 2018 | 3 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 233 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2019 | 155 | 0.040 |
Why?
|
| Uterus | 1 | 2023 | 539 | 0.040 |
Why?
|
| Drug Storage | 1 | 1998 | 18 | 0.040 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2020 | 179 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2020 | 346 | 0.040 |
Why?
|
| Pets | 1 | 2018 | 19 | 0.040 |
Why?
|
| Computer Communication Networks | 1 | 2018 | 17 | 0.040 |
Why?
|
| Language | 1 | 2020 | 216 | 0.040 |
Why?
|
| Ubiquitins | 1 | 1998 | 40 | 0.040 |
Why?
|
| Dopamine | 1 | 2020 | 251 | 0.040 |
Why?
|
| Genes, rRNA | 2 | 2011 | 19 | 0.040 |
Why?
|
| Leukocyte Count | 2 | 2017 | 249 | 0.040 |
Why?
|
| Cytochrome P450 Family 4 | 1 | 2018 | 5 | 0.040 |
Why?
|
| Body Patterning | 1 | 2019 | 127 | 0.040 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 2018 | 16 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2018 | 61 | 0.040 |
Why?
|
| Pancreas | 1 | 2019 | 222 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2012 | 604 | 0.040 |
Why?
|
| Biophysical Phenomena | 1 | 2018 | 39 | 0.030 |
Why?
|
| Insulin-Secreting Cells | 1 | 2019 | 136 | 0.030 |
Why?
|
| Receptor, Notch2 | 1 | 2018 | 12 | 0.030 |
Why?
|
| Synaptic Vesicles | 1 | 2018 | 68 | 0.030 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2018 | 15 | 0.030 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2018 | 22 | 0.030 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2018 | 35 | 0.030 |
Why?
|
| Breeding | 1 | 2018 | 19 | 0.030 |
Why?
|
| Hominidae | 2 | 2014 | 27 | 0.030 |
Why?
|
| Demyelinating Diseases | 1 | 2018 | 69 | 0.030 |
Why?
|
| Bifidobacterium | 1 | 2018 | 65 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2016 | 2107 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2019 | 426 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 64 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2020 | 280 | 0.030 |
Why?
|
| Deoxyadenine Nucleotides | 1 | 1997 | 6 | 0.030 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2017 | 9 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 245 | 0.030 |
Why?
|
| X-Rays | 2 | 1989 | 30 | 0.030 |
Why?
|
| DNA, Ribosomal Spacer | 1 | 2017 | 8 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 1999 | 263 | 0.030 |
Why?
|
| Malassezia | 1 | 2017 | 6 | 0.030 |
Why?
|
| Endocytosis | 1 | 2018 | 126 | 0.030 |
Why?
|
| Nervous System Malformations | 1 | 2019 | 136 | 0.030 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2017 | 21 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2018 | 121 | 0.030 |
Why?
|
| Pregnancy | 6 | 2018 | 7381 | 0.030 |
Why?
|
| Infant Care | 1 | 2017 | 45 | 0.030 |
Why?
|
| Information Services | 1 | 2017 | 23 | 0.030 |
Why?
|
| Copepoda | 1 | 2017 | 6 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2018 | 187 | 0.030 |
Why?
|
| Crustacea | 1 | 2017 | 6 | 0.030 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2017 | 13 | 0.030 |
Why?
|
| Cardiac Myosins | 1 | 2017 | 11 | 0.030 |
Why?
|
| Kallikreins | 1 | 2017 | 26 | 0.030 |
Why?
|
| Incidence | 2 | 2017 | 3328 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2018 | 116 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2017 | 131 | 0.030 |
Why?
|
| Immunological Synapses | 1 | 2018 | 32 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2018 | 77 | 0.030 |
Why?
|
| Tropomyosin | 1 | 2017 | 26 | 0.030 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2018 | 77 | 0.030 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2018 | 80 | 0.030 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 1997 | 15 | 0.030 |
Why?
|
| Receptors, CCR5 | 1 | 1997 | 29 | 0.030 |
Why?
|
| Epithelium | 1 | 2018 | 339 | 0.030 |
Why?
|
| Heart Atria | 1 | 2020 | 333 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 136 | 0.030 |
Why?
|
| Antipsychotic Agents | 1 | 2020 | 364 | 0.030 |
Why?
|
| Laminin | 1 | 2017 | 68 | 0.030 |
Why?
|
| Viremia | 1 | 2018 | 131 | 0.030 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2017 | 32 | 0.030 |
Why?
|
| Population Groups | 1 | 2017 | 31 | 0.030 |
Why?
|
| Candida | 1 | 2017 | 78 | 0.030 |
Why?
|
| Adenosine Diphosphate | 1 | 2017 | 50 | 0.030 |
Why?
|
| Citric Acid | 1 | 2017 | 45 | 0.030 |
Why?
|
| Gametogenesis | 1 | 2017 | 26 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2018 | 238 | 0.030 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2017 | 39 | 0.030 |
Why?
|
| Philadelphia Chromosome | 1 | 2017 | 41 | 0.030 |
Why?
|
| Facial Paralysis | 1 | 2017 | 36 | 0.030 |
Why?
|
| HIV Infections | 2 | 2002 | 2013 | 0.030 |
Why?
|
| Femur Neck | 1 | 2016 | 16 | 0.030 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2017 | 31 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2018 | 137 | 0.030 |
Why?
|
| CD56 Antigen | 1 | 2016 | 26 | 0.030 |
Why?
|
| Chondrogenesis | 1 | 2017 | 30 | 0.030 |
Why?
|
| Cartilage | 1 | 2017 | 51 | 0.030 |
Why?
|
| Massachusetts | 1 | 2017 | 115 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2017 | 93 | 0.030 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 241 | 0.030 |
Why?
|
| Trees | 1 | 2016 | 20 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2018 | 272 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2019 | 221 | 0.030 |
Why?
|
| Aeromonas hydrophila | 1 | 2016 | 3 | 0.030 |
Why?
|
| Oryzias | 1 | 2016 | 9 | 0.030 |
Why?
|
| Autoantigens | 1 | 1997 | 99 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 2018 | 235 | 0.030 |
Why?
|
| MEF2 Transcription Factors | 1 | 2016 | 35 | 0.030 |
Why?
|
| Epidemiologic Studies | 1 | 2016 | 40 | 0.030 |
Why?
|
| Motor Activity | 1 | 2020 | 497 | 0.030 |
Why?
|
| PAX2 Transcription Factor | 1 | 2016 | 27 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2018 | 229 | 0.030 |
Why?
|
| Amiloride | 1 | 2016 | 30 | 0.030 |
Why?
|
| Twins, Monozygotic | 1 | 2017 | 124 | 0.030 |
Why?
|
| Renin | 1 | 2016 | 75 | 0.030 |
Why?
|
| Eczema | 1 | 2016 | 34 | 0.030 |
Why?
|
| RNA Ligase (ATP) | 1 | 1996 | 1 | 0.030 |
Why?
|
| Bacteriophage T4 | 1 | 1996 | 2 | 0.030 |
Why?
|
| Tetranychidae | 1 | 2016 | 1 | 0.030 |
Why?
|
| Phosphorus | 1 | 2017 | 61 | 0.030 |
Why?
|
| Aldosterone | 1 | 2016 | 58 | 0.030 |
Why?
|
| Ophthalmoplegia | 1 | 2017 | 52 | 0.030 |
Why?
|
| Thiolester Hydrolases | 1 | 1996 | 6 | 0.030 |
Why?
|
| Consent Forms | 1 | 2016 | 22 | 0.030 |
Why?
|
| Coroners and Medical Examiners | 1 | 2016 | 15 | 0.030 |
Why?
|
| Ocular Motility Disorders | 1 | 2017 | 38 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2019 | 315 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2018 | 178 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2021 | 3105 | 0.030 |
Why?
|
| HIV | 1 | 2018 | 177 | 0.030 |
Why?
|
| Fusion Proteins, gag-pol | 1 | 1996 | 4 | 0.030 |
Why?
|
| Hypokalemia | 1 | 2016 | 40 | 0.030 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2016 | 17 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2017 | 105 | 0.030 |
Why?
|
| Reproductive Isolation | 1 | 2016 | 5 | 0.030 |
Why?
|
| Sympatry | 1 | 2016 | 4 | 0.030 |
Why?
|
| Hydrochlorothiazide | 1 | 2016 | 67 | 0.030 |
Why?
|
| Everolimus | 1 | 2016 | 48 | 0.030 |
Why?
|
| HIV Long Terminal Repeat | 1 | 1996 | 17 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2016 | 76 | 0.030 |
Why?
|
| Magnesium | 1 | 2017 | 114 | 0.030 |
Why?
|
| Biotin | 1 | 1996 | 40 | 0.030 |
Why?
|
| Proteome | 2 | 2013 | 290 | 0.030 |
Why?
|
| Diagnosis | 1 | 2016 | 29 | 0.030 |
Why?
|
| Pyrroles | 1 | 1997 | 184 | 0.030 |
Why?
|
| Virulence Factors | 1 | 2017 | 180 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-gamma | 1 | 2016 | 4 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2016 | 22 | 0.030 |
Why?
|
| Patient Admission | 1 | 2017 | 184 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2022 | 806 | 0.030 |
Why?
|
| Adaptation, Biological | 1 | 2016 | 33 | 0.030 |
Why?
|
| alpha-Synuclein | 1 | 2017 | 141 | 0.030 |
Why?
|
| Virus Assembly | 1 | 1996 | 37 | 0.030 |
Why?
|
| Epinephrine | 1 | 2017 | 143 | 0.030 |
Why?
|
| Carbapenems | 1 | 2016 | 44 | 0.030 |
Why?
|
| Megakaryocytes | 1 | 2016 | 42 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2016 | 192 | 0.030 |
Why?
|
| beta-Lactam Resistance | 1 | 2016 | 48 | 0.030 |
Why?
|
| Orbital Diseases | 1 | 2017 | 66 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2016 | 27 | 0.030 |
Why?
|
| Synapses | 1 | 2020 | 448 | 0.030 |
Why?
|
| Wnt-5a Protein | 1 | 2016 | 23 | 0.030 |
Why?
|
| Ampulla of Vater | 1 | 2016 | 15 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1996 | 53 | 0.030 |
Why?
|
| Glycolysis | 1 | 1997 | 174 | 0.030 |
Why?
|
| Click Chemistry | 1 | 2015 | 7 | 0.030 |
Why?
|
| Protein Prenylation | 1 | 2015 | 8 | 0.030 |
Why?
|
| Hemolymph | 1 | 2015 | 3 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 172 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 2017 | 236 | 0.030 |
Why?
|
| Mobile Applications | 1 | 2017 | 110 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1996 | 78 | 0.030 |
Why?
|
| Defensins | 1 | 2015 | 7 | 0.030 |
Why?
|
| Sex Factors | 1 | 2020 | 1334 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2017 | 759 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2016 | 159 | 0.030 |
Why?
|
| Caenorhabditis | 1 | 1995 | 6 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 2017 | 124 | 0.030 |
Why?
|
| Ovary | 1 | 1998 | 351 | 0.030 |
Why?
|
| Data Mining | 1 | 2016 | 65 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 256 | 0.030 |
Why?
|
| Alkynes | 1 | 2015 | 26 | 0.030 |
Why?
|
| Cysteine | 1 | 2016 | 137 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2018 | 343 | 0.030 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2015 | 8 | 0.030 |
Why?
|
| Gene Products, pol | 1 | 1995 | 5 | 0.030 |
Why?
|
| Action Potentials | 1 | 2018 | 465 | 0.030 |
Why?
|
| Reoperation | 1 | 2019 | 831 | 0.030 |
Why?
|
| Chromosome Walking | 1 | 1995 | 8 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 1608 | 0.030 |
Why?
|
| Myelin P0 Protein | 1 | 2015 | 28 | 0.030 |
Why?
|
| Database Management Systems | 1 | 2015 | 26 | 0.030 |
Why?
|
| Genome, Fungal | 1 | 1995 | 34 | 0.030 |
Why?
|
| Defective Viruses | 1 | 1995 | 17 | 0.030 |
Why?
|
| Histone Demethylases | 1 | 2016 | 42 | 0.030 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2015 | 17 | 0.030 |
Why?
|
| Neck | 1 | 2016 | 142 | 0.030 |
Why?
|
| Gene Products, gag | 1 | 1995 | 20 | 0.030 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2015 | 38 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 1377 | 0.030 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1995 | 42 | 0.030 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2015 | 22 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1996 | 148 | 0.030 |
Why?
|
| Cloud Computing | 1 | 2015 | 15 | 0.030 |
Why?
|
| Confidentiality | 1 | 2016 | 105 | 0.030 |
Why?
|
| Milk, Human | 1 | 2018 | 312 | 0.030 |
Why?
|
| Suppression, Genetic | 1 | 2015 | 41 | 0.030 |
Why?
|
| Neocortex | 1 | 2016 | 75 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2016 | 307 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2016 | 178 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2017 | 410 | 0.030 |
Why?
|
| Gene-Environment Interaction | 1 | 2016 | 126 | 0.030 |
Why?
|
| Bee Venoms | 1 | 2015 | 6 | 0.030 |
Why?
|
| Dystrophin | 2 | 1992 | 40 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2017 | 288 | 0.030 |
Why?
|
| Fabry Disease | 1 | 1995 | 18 | 0.030 |
Why?
|
| Liver | 2 | 2021 | 1797 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 1300 | 0.030 |
Why?
|
| Microcomputers | 1 | 1995 | 11 | 0.030 |
Why?
|
| Gene Components | 1 | 2015 | 8 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2015 | 54 | 0.030 |
Why?
|
| Echocardiography | 1 | 2021 | 1125 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 5186 | 0.030 |
Why?
|
| Disclosure | 1 | 2016 | 150 | 0.030 |
Why?
|
| Elective Surgical Procedures | 1 | 2016 | 158 | 0.030 |
Why?
|
| Fibrillins | 1 | 2015 | 28 | 0.030 |
Why?
|
| Lod Score | 1 | 2015 | 126 | 0.030 |
Why?
|
| Physical Examination | 1 | 2016 | 160 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2016 | 248 | 0.030 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2015 | 17 | 0.030 |
Why?
|
| DCC Receptor | 1 | 2015 | 5 | 0.030 |
Why?
|
| Interview, Psychological | 1 | 2015 | 101 | 0.030 |
Why?
|
| Microscopy, Acoustic | 1 | 2015 | 15 | 0.030 |
Why?
|
| Protein Folding | 1 | 2016 | 215 | 0.030 |
Why?
|
| Emergencies | 1 | 2016 | 176 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2017 | 833 | 0.030 |
Why?
|
| Blood Proteins | 1 | 2015 | 139 | 0.030 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2014 | 12 | 0.030 |
Why?
|
| Fibrillin-1 | 1 | 2015 | 60 | 0.030 |
Why?
|
| Immune System | 1 | 2015 | 99 | 0.030 |
Why?
|
| Oligodendroglioma | 1 | 2014 | 26 | 0.030 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2015 | 47 | 0.030 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2015 | 31 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 145 | 0.030 |
Why?
|
| Scotoma | 1 | 2015 | 16 | 0.030 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2015 | 44 | 0.030 |
Why?
|
| Taq Polymerase | 2 | 1997 | 7 | 0.030 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2014 | 7 | 0.030 |
Why?
|
| Sex Chromosomes | 1 | 2014 | 29 | 0.030 |
Why?
|
| HIV Protease | 1 | 1994 | 3 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 1996 | 234 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2015 | 145 | 0.030 |
Why?
|
| Sulfonylurea Receptors | 1 | 2014 | 12 | 0.030 |
Why?
|
| Replication Origin | 1 | 2014 | 12 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2016 | 192 | 0.030 |
Why?
|
| Genetic Code | 1 | 2014 | 22 | 0.030 |
Why?
|
| Archaea | 1 | 2014 | 9 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 215 | 0.030 |
Why?
|
| Motor Neurons | 1 | 2015 | 136 | 0.030 |
Why?
|
| Self Report | 1 | 2018 | 555 | 0.030 |
Why?
|
| Vitamin B Complex | 1 | 2015 | 35 | 0.030 |
Why?
|
| Electroretinography | 1 | 2015 | 107 | 0.030 |
Why?
|
| Fibrosarcoma | 1 | 1994 | 22 | 0.030 |
Why?
|
| DNA Polymerase III | 1 | 2014 | 24 | 0.030 |
Why?
|
| Prostaglandins F | 1 | 2014 | 8 | 0.030 |
Why?
|
| Patients | 1 | 2015 | 122 | 0.030 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2014 | 8 | 0.030 |
Why?
|
| Neutrophils | 1 | 2017 | 358 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 455 | 0.030 |
Why?
|
| Proteolysis | 1 | 2015 | 197 | 0.030 |
Why?
|
| Protein Domains | 1 | 2015 | 253 | 0.030 |
Why?
|
| Transcription Termination, Genetic | 1 | 2014 | 13 | 0.030 |
Why?
|
| Vitamin B 12 | 1 | 2015 | 58 | 0.030 |
Why?
|
| Hypercalciuria | 1 | 2014 | 9 | 0.030 |
Why?
|
| Wool | 1 | 2014 | 3 | 0.030 |
Why?
|
| Keratins, Hair-Specific | 1 | 2014 | 3 | 0.030 |
Why?
|
| Cricetinae | 3 | 1993 | 362 | 0.030 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type I | 1 | 2014 | 5 | 0.030 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2014 | 5 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 1275 | 0.030 |
Why?
|
| Hamartoma | 1 | 2015 | 51 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2014 | 32 | 0.030 |
Why?
|
| Puerto Rico | 1 | 2014 | 49 | 0.030 |
Why?
|
| Vision Tests | 1 | 2014 | 24 | 0.030 |
Why?
|
| Uracil-DNA Glycosidase | 1 | 1994 | 5 | 0.030 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2014 | 39 | 0.030 |
Why?
|
| Marsupialia | 1 | 2014 | 2 | 0.030 |
Why?
|
| Paired Box Transcription Factors | 1 | 2014 | 73 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2014 | 29 | 0.030 |
Why?
|
| Corneal Opacity | 1 | 2014 | 21 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1994 | 129 | 0.030 |
Why?
|
| Hypercalcemia | 1 | 2014 | 41 | 0.030 |
Why?
|
| Mice, Inbred CBA | 1 | 2014 | 27 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2014 | 33 | 0.030 |
Why?
|
| Integrases | 1 | 1995 | 157 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 1 | 2014 | 174 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1994 | 280 | 0.030 |
Why?
|
| Spine | 1 | 2015 | 154 | 0.030 |
Why?
|
| Adipokines | 1 | 2015 | 120 | 0.030 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2014 | 46 | 0.030 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2014 | 24 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2016 | 220 | 0.030 |
Why?
|
| Radiography, Abdominal | 1 | 2014 | 43 | 0.030 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2015 | 80 | 0.030 |
Why?
|
| Telomere Shortening | 1 | 2014 | 33 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 160 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2015 | 137 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2014 | 120 | 0.030 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2017 | 324 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 62 | 0.030 |
Why?
|
| Lipase | 1 | 2014 | 88 | 0.030 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 98 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2016 | 396 | 0.030 |
Why?
|
| Fatty Acids, Volatile | 1 | 2014 | 43 | 0.030 |
Why?
|
| Cerebrum | 1 | 2014 | 32 | 0.030 |
Why?
|
| Microphthalmos | 1 | 2014 | 54 | 0.030 |
Why?
|
| Gastrulation | 1 | 2014 | 27 | 0.030 |
Why?
|
| src-Family Kinases | 1 | 2014 | 92 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2014 | 84 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 199 | 0.030 |
Why?
|
| Neurologic Manifestations | 1 | 2013 | 4 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2015 | 180 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2015 | 130 | 0.030 |
Why?
|
| Reference Standards | 1 | 2014 | 231 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2014 | 124 | 0.030 |
Why?
|
| Mice, Mutant Strains | 3 | 1989 | 358 | 0.030 |
Why?
|
| Neurofibromin 1 | 1 | 2014 | 59 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1994 | 413 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 837 | 0.030 |
Why?
|
| Blindness, Cortical | 1 | 2013 | 15 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 165 | 0.030 |
Why?
|
| Disease Management | 1 | 2017 | 559 | 0.030 |
Why?
|
| Hepatitis B virus | 1 | 2014 | 137 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2015 | 240 | 0.030 |
Why?
|
| Gene Editing | 1 | 2016 | 227 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2014 | 114 | 0.030 |
Why?
|
| Visual Fields | 1 | 2015 | 139 | 0.030 |
Why?
|
| Forearm | 1 | 2013 | 39 | 0.030 |
Why?
|
| Bile Acids and Salts | 1 | 2016 | 259 | 0.030 |
Why?
|
| Abdomen | 1 | 2014 | 129 | 0.030 |
Why?
|
| Animals, Outbred Strains | 1 | 2013 | 10 | 0.030 |
Why?
|
| Markov Chains | 1 | 2014 | 101 | 0.030 |
Why?
|
| Calcium | 1 | 2018 | 1027 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 2014 | 117 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 416 | 0.020 |
Why?
|
| Population Control | 1 | 2013 | 4 | 0.020 |
Why?
|
| Receptor, Notch3 | 1 | 2013 | 12 | 0.020 |
Why?
|
| Models, Biological | 2 | 2008 | 1390 | 0.020 |
Why?
|
| Electrophoresis | 1 | 1993 | 32 | 0.020 |
Why?
|
| Caspase 8 | 1 | 2013 | 25 | 0.020 |
Why?
|
| Brachydactyly | 1 | 2013 | 10 | 0.020 |
Why?
|
| Software Design | 1 | 1993 | 21 | 0.020 |
Why?
|
| Dyslipidemias | 1 | 2016 | 251 | 0.020 |
Why?
|
| Italy | 1 | 2013 | 111 | 0.020 |
Why?
|
| Blotting, Western | 1 | 1995 | 1019 | 0.020 |
Why?
|
| Adenoma | 1 | 2015 | 145 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 479 | 0.020 |
Why?
|
| CRISPR-Cas Systems | 1 | 2016 | 317 | 0.020 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2013 | 25 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2015 | 600 | 0.020 |
Why?
|
| Toes | 1 | 2013 | 28 | 0.020 |
Why?
|
| Metabolomics | 1 | 2017 | 504 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2017 | 687 | 0.020 |
Why?
|
| Panax | 1 | 2012 | 7 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2014 | 319 | 0.020 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2013 | 25 | 0.020 |
Why?
|
| Body Weight | 1 | 2017 | 985 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2014 | 168 | 0.020 |
Why?
|
| Biotransformation | 1 | 2012 | 54 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1993 | 227 | 0.020 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2012 | 21 | 0.020 |
Why?
|
| NAV1.4 Voltage-Gated Sodium Channel | 1 | 2012 | 4 | 0.020 |
Why?
|
| Ampicillin Resistance | 1 | 2012 | 18 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1994 | 985 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 454 | 0.020 |
Why?
|
| Viruses | 1 | 1994 | 117 | 0.020 |
Why?
|
| Caco-2 Cells | 1 | 2012 | 86 | 0.020 |
Why?
|
| RNA, Bacterial | 1 | 2012 | 59 | 0.020 |
Why?
|
| Hepacivirus | 1 | 2014 | 273 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2012 | 58 | 0.020 |
Why?
|
| RNA, Spliced Leader | 1 | 2012 | 2 | 0.020 |
Why?
|
| Trans-Splicing | 1 | 2012 | 2 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2017 | 757 | 0.020 |
Why?
|
| Biological Availability | 1 | 2012 | 138 | 0.020 |
Why?
|
| Solubility | 1 | 2012 | 117 | 0.020 |
Why?
|
| Hand | 1 | 2013 | 95 | 0.020 |
Why?
|
| Calcium Channels, L-Type | 1 | 2012 | 51 | 0.020 |
Why?
|
| Exosomes | 1 | 2013 | 62 | 0.020 |
Why?
|
| Fetal Diseases | 1 | 2016 | 445 | 0.020 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2013 | 50 | 0.020 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2012 | 38 | 0.020 |
Why?
|
| Scrotum | 1 | 2012 | 26 | 0.020 |
Why?
|
| Myocardium | 1 | 2017 | 859 | 0.020 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2014 | 154 | 0.020 |
Why?
|
| Radiation Hybrid Mapping | 1 | 2012 | 5 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2012 | 145 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2012 | 50 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 64 | 0.020 |
Why?
|
| Anthropometry | 1 | 2012 | 187 | 0.020 |
Why?
|
| Critical Care | 1 | 2017 | 684 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2014 | 324 | 0.020 |
Why?
|
| Rubinstein-Taybi Syndrome | 1 | 2012 | 16 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2014 | 938 | 0.020 |
Why?
|
| Length of Stay | 1 | 2017 | 1392 | 0.020 |
Why?
|
| Codon | 1 | 1991 | 93 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2012 | 125 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 81 | 0.020 |
Why?
|
| Smad4 Protein | 1 | 2012 | 58 | 0.020 |
Why?
|
| Cleft Palate | 1 | 2015 | 219 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 243 | 0.020 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2011 | 20 | 0.020 |
Why?
|
| Protein Interaction Maps | 1 | 2012 | 93 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2014 | 463 | 0.020 |
Why?
|
| Rhodopsin | 1 | 2011 | 65 | 0.020 |
Why?
|
| Electron Transport Complex IV | 2 | 2004 | 41 | 0.020 |
Why?
|
| Chromosomes, Fungal | 1 | 1991 | 48 | 0.020 |
Why?
|
| Linear Models | 1 | 2013 | 688 | 0.020 |
Why?
|
| Antigens | 1 | 2011 | 104 | 0.020 |
Why?
|
| Programming Languages | 1 | 2011 | 17 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2014 | 569 | 0.020 |
Why?
|
| Cerebrosides | 1 | 2011 | 4 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2016 | 1065 | 0.020 |
Why?
|
| Thorax | 1 | 2011 | 66 | 0.020 |
Why?
|
| Australia | 1 | 2011 | 171 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1617 | 0.020 |
Why?
|
| Machine Learning | 1 | 2015 | 385 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 257 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2013 | 219 | 0.020 |
Why?
|
| Somatostatin | 1 | 2011 | 60 | 0.020 |
Why?
|
| Ribonuclease, Pancreatic | 2 | 1988 | 20 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2014 | 555 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 293 | 0.020 |
Why?
|
| Heart Rate | 1 | 2014 | 574 | 0.020 |
Why?
|
| Geography | 1 | 2010 | 116 | 0.020 |
Why?
|
| Breast | 1 | 2012 | 214 | 0.020 |
Why?
|
| Photoreceptor Cells | 1 | 2011 | 90 | 0.020 |
Why?
|
| Calibration | 1 | 2010 | 92 | 0.020 |
Why?
|
| Carcinogenesis | 1 | 2013 | 345 | 0.020 |
Why?
|
| Checklist | 1 | 2011 | 97 | 0.020 |
Why?
|
| Papillomaviridae | 1 | 2011 | 178 | 0.020 |
Why?
|
| India | 1 | 2010 | 243 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2013 | 1215 | 0.020 |
Why?
|
| Chromosomes, Bacterial | 2 | 2000 | 64 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2012 | 291 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 1 | 2015 | 449 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2011 | 701 | 0.020 |
Why?
|
| Body Composition | 1 | 2012 | 551 | 0.020 |
Why?
|
| Virulence | 1 | 2010 | 269 | 0.020 |
Why?
|
| Genomic Islands | 1 | 2009 | 29 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2005 | 274 | 0.020 |
Why?
|
| RNA | 2 | 2005 | 520 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2012 | 583 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2014 | 963 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 1990 | 72 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 1262 | 0.020 |
Why?
|
| Inteins | 1 | 2009 | 3 | 0.020 |
Why?
|
| Ciliary Body | 1 | 2009 | 18 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2011 | 295 | 0.020 |
Why?
|
| Locus Control Region | 1 | 2008 | 7 | 0.020 |
Why?
|
| Premature Birth | 1 | 2013 | 421 | 0.020 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2008 | 15 | 0.020 |
Why?
|
| Uveitis | 1 | 2009 | 33 | 0.020 |
Why?
|
| Physicians | 1 | 2015 | 634 | 0.020 |
Why?
|
| DNA, Single-Stranded | 1 | 1989 | 69 | 0.020 |
Why?
|
| Guanylate Cyclase | 1 | 2008 | 33 | 0.020 |
Why?
|
| cis-trans-Isomerases | 1 | 2008 | 9 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 361 | 0.020 |
Why?
|
| Fusidic Acid | 1 | 2008 | 4 | 0.020 |
Why?
|
| Deoxyuracil Nucleotides | 1 | 2008 | 6 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2008 | 33 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2013 | 537 | 0.020 |
Why?
|
| RNA, Small Untranslated | 1 | 2008 | 20 | 0.020 |
Why?
|
| RNA Nucleotidyltransferases | 1 | 2008 | 32 | 0.020 |
Why?
|
| Pulmonary Surfactants | 1 | 2008 | 45 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 68 | 0.020 |
Why?
|
| Operon | 1 | 2008 | 50 | 0.020 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 1988 | 10 | 0.020 |
Why?
|
| Karyotyping | 1 | 2008 | 312 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 706 | 0.020 |
Why?
|
| Urate Oxidase | 1 | 1988 | 16 | 0.020 |
Why?
|
| Individuality | 1 | 2008 | 36 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 1989 | 191 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2008 | 143 | 0.020 |
Why?
|
| Tretinoin | 1 | 2008 | 95 | 0.020 |
Why?
|
| RNA Stability | 1 | 2008 | 75 | 0.020 |
Why?
|
| Thyroid Nuclear Factor 1 | 1 | 2007 | 9 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2008 | 180 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2012 | 765 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 2007 | 148 | 0.020 |
Why?
|
| Ornithine Decarboxylase | 1 | 1987 | 19 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 2346 | 0.020 |
Why?
|
| Cats | 1 | 2007 | 113 | 0.020 |
Why?
|
| Biofilms | 1 | 2008 | 94 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 1152 | 0.020 |
Why?
|
| Rifampin | 1 | 2008 | 122 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 1990 | 266 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1987 | 132 | 0.020 |
Why?
|
| Gamma Rays | 1 | 1987 | 39 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 1987 | 65 | 0.020 |
Why?
|
| Rabbits | 1 | 2007 | 574 | 0.020 |
Why?
|
| Monocytes | 1 | 2008 | 336 | 0.020 |
Why?
|
| Dogs | 1 | 2007 | 615 | 0.020 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2006 | 18 | 0.020 |
Why?
|
| HIV Antibodies | 2 | 2000 | 69 | 0.020 |
Why?
|
| Diet | 1 | 2012 | 1097 | 0.010 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2008 | 392 | 0.010 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2005 | 55 | 0.010 |
Why?
|
| Frameshifting, Ribosomal | 1 | 2004 | 3 | 0.010 |
Why?
|
| Rickettsia conorii | 1 | 2004 | 4 | 0.010 |
Why?
|
| Prenatal Diagnosis | 4 | 1991 | 623 | 0.010 |
Why?
|
| Rickettsia | 1 | 2004 | 16 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 2004 | 121 | 0.010 |
Why?
|
| Untranslated Regions | 1 | 2004 | 8 | 0.010 |
Why?
|
| Protein Structure, Quaternary | 1 | 2004 | 92 | 0.010 |
Why?
|
| West Nile virus | 1 | 2005 | 120 | 0.010 |
Why?
|
| Subtraction Technique | 1 | 2003 | 36 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 487 | 0.010 |
Why?
|
| CHO Cells | 2 | 1993 | 151 | 0.010 |
Why?
|
| Histones | 1 | 2006 | 546 | 0.010 |
Why?
|
| GC Rich Sequence | 1 | 2001 | 6 | 0.010 |
Why?
|
| Public Sector | 1 | 2001 | 17 | 0.010 |
Why?
|
| Private Sector | 1 | 2001 | 26 | 0.010 |
Why?
|
| Drug Industry | 1 | 2001 | 48 | 0.010 |
Why?
|
| Receptors, Androgen | 1 | 2004 | 415 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2004 | 955 | 0.010 |
Why?
|
| Salivary Glands | 1 | 2000 | 35 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2000 | 92 | 0.010 |
Why?
|
| Administration, Intranasal | 1 | 2000 | 129 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2004 | 675 | 0.010 |
Why?
|
| Sequence Tagged Sites | 1 | 2000 | 27 | 0.010 |
Why?
|
| Poly A | 1 | 1999 | 45 | 0.010 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2000 | 107 | 0.010 |
Why?
|
| Immunization | 1 | 2000 | 265 | 0.010 |
Why?
|
| Biological Transport | 1 | 2000 | 332 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2000 | 441 | 0.010 |
Why?
|
| Hippocampus | 1 | 2004 | 801 | 0.010 |
Why?
|
| DNA Polymerase I | 1 | 1997 | 10 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1999 | 348 | 0.010 |
Why?
|
| snRNP Core Proteins | 1 | 1997 | 8 | 0.010 |
Why?
|
| DNA-Cytosine Methylases | 1 | 1997 | 6 | 0.010 |
Why?
|
| Methylation | 1 | 1997 | 197 | 0.010 |
Why?
|
| Hospitalization | 1 | 2005 | 1927 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 2545 | 0.010 |
Why?
|
| Dinucleoside Phosphates | 1 | 1996 | 12 | 0.010 |
Why?
|
| Creatine | 1 | 1996 | 38 | 0.010 |
Why?
|
| Polydeoxyribonucleotides | 1 | 1991 | 3 | 0.010 |
Why?
|
| Placenta | 1 | 1996 | 516 | 0.010 |
Why?
|
| Nucleotide Mapping | 1 | 1991 | 12 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1991 | 47 | 0.010 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1990 | 41 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1991 | 809 | 0.000 |
Why?
|
| HIV Seropositivity | 1 | 1990 | 122 | 0.000 |
Why?
|
| Sexual Behavior | 1 | 1990 | 238 | 0.000 |
Why?
|
| Mice, Inbred ICR | 1 | 1988 | 136 | 0.000 |
Why?
|
| Stem Cells | 1 | 1991 | 713 | 0.000 |
Why?
|
| Swine | 1 | 1988 | 1184 | 0.000 |
Why?
|